CN1034925A - 喹啉、喹唑啉和噌啉类杀真菌剂 - Google Patents

喹啉、喹唑啉和噌啉类杀真菌剂 Download PDF

Info

Publication number
CN1034925A
CN1034925A CN89100472A CN89100472A CN1034925A CN 1034925 A CN1034925 A CN 1034925A CN 89100472 A CN89100472 A CN 89100472A CN 89100472 A CN89100472 A CN 89100472A CN 1034925 A CN1034925 A CN 1034925A
Authority
CN
China
Prior art keywords
formula
compound
chloro
quinoline
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN89100472A
Other languages
English (en)
Other versions
CN1031263C (zh
Inventor
温德尔·雷·阿诺德
迈克尔·约瑟夫·科格伦
艾力史斯·维史托·克伦卡尔恩斯
格兰·菲尔·佐丹
罗伯特·乔治·苏尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corteva Agriscience LLC
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of CN1034925A publication Critical patent/CN1034925A/zh
Application granted granted Critical
Publication of CN1031263C publication Critical patent/CN1031263C/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/233Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • A01N43/42Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/541,3-Diazines; Hydrogenated 1,3-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/581,2-Diazines; Hydrogenated 1,2-diazines
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/713Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with four or more nitrogen atoms as the only ring hetero atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • C07D215/44Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/58Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems with hetero atoms directly attached to the ring nitrogen atom
    • C07D215/60N-oxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/06Ring systems of three rings
    • C07D221/16Ring systems of three rings containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/28Cinnolines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

式(1)化合物或式(1)化合物的酸加成盐或Y为 CH的式(1)化合物的N-氧化物为植物杀真菌剂。 其中R1、R2、R3、R4、A、X、Y、Z的含义如说明书所 述。

Description

本发明提供具有极好的植物杀真菌活性的新化合物。某些化合物还表现出杀昆虫和杀螨活性。本发明还提供含有本发明化合物作为活性成分的组合物和结合产品。某些结合产品对于抵抗植物病原体表现出增效活性。本发明还提供杀真菌方法。
由于目标病原体对已知的杀真菌剂迅速产生抗性,所以急需一些新的杀真菌剂。1983年观察到N-取代吡咯类杀真菌剂普遍不能控制大麦白粉病,这被认为是由于抗性的产生。目前普遍依靠DMI(脱甲基    抑制剂)类杀真菌剂来预防谷类作物的白粉病,但从七十年代推出该杀真菌剂以来,它的田间性能已有所下降。导致葡萄孢病的病原群体是葡萄乃至浆果作物的头号病害,也是蕃茄和黄瓜等温室作物的头号病害,这个病原群体同样也转变为对苯并咪唑和二甲酰亚胺类杀真菌剂具有抗性的菌株。
本发明提供一种杀真菌方法,该方法包括,向真菌出没地点施用有效杀真菌量的式(1)化合物或式(1)化合物的酸加成盐,或Y为CH的式(1)化合物的N-氧化物。
Figure 891004726_IMG14
式中
X为CR5或N,其中R5为H、Cl或CH3;
如果X为N,则Y为CR5′;如果X为CR5,则Y为CR5′或N,其中R5′为H、Cl或Br;
Z为O、S、SO、SO2、NR6,其中R6为H、(C1-C4)烷基、或(C1-C4)酰基、或CR7R8,其中R7和R8彼此独立地为H、(C1-C4)酰基、(C1-C4)烷基、(C1-C4)链烯基、(C2-C4)炔基、CN、或OH,或R7和R8结合而形成含4至6个碳原子的碳环。
R1至R4彼此独立地为H、OH、NO2、卤素、I、(C1-C4)烷基、(C3-C4)支链烷基、(C1-C4)烷氧基、卤代(C1-C4)烷基、卤代(C1-C4)烷氧基、或卤代(C1-C4)烷硫基;或者R1和R2或R2和R3结合而形成含4至6个碳原子的碳环;
A为
(a)饱和或不饱和的、直链或支链的C1-C18碳氢链,其中可任意含有一个选自O、S、SO、SO2、或Si的杂原子,并可被卤素、卤代(C1-C4)烷氧基、羟基、或(C1-C4)酰基取代;
(b)(C3-C8)环烷基或环烯基;
(c)具有式(2)的苯基
Figure 891004726_IMG15
式中R9至R13彼此独立地为
H、
CN、
NO2
OH、
卤素、
I、
(C1-C4)烷基、
(C3-C4)支链烷基、
(C2-C4)酰基、
卤代(C1-C4)烷基、
羟基(C1-C4)烷基、
(C1-C4)烷氧基、
卤代(C1-C4)烷氧基、
(C1-C4)烷硫基、
卤代(C1-C4)烷硫基、
苯基、
取代的苯基、
苯氧基、
取代的苯氧基、
苯硫基、
取代的苯硫基、
苯基(C1-C4)烷基、
取代的苯基(C1-C4)烷基、
苯甲酰基、
取代的苯甲酰基、
SiR20R21R22或OSiR20R21R22,其中,R20、R21和R22为H、直链或支链C1-C6烷基、苯基、或取代的苯基,条件是,R20、R21和R22至少有一个不为H,或者R11和R12或R12和R13合并而形成一个碳环,条件是,R9至R13中至少有两个为H,除非R9至R13都为H或F;
(d)具有式(3)的呋喃基
Figure 891004726_IMG16
其中R14为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基,
(e)具有式(4)的噻吩基
其中R15为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基;
(f)具有式(5)或(5a)的基团
其中R16为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、取代的苯基、或(C1-C4)烷氧基,而F为N或CH,G为O、NR19或CH,条件是,或者F为N,或者G为NR19,其中R19为H、(C1-C4)烷基、(C1-C4)酰基、苯磺酰基、或取代的苯磺酰基;
(g)选自如下基团之一:
1-萘基、
取代的1-萘基、
4-吡唑基、
3-甲基-4-吡唑基、
1,3-苯并二噁茂基、
三环〔3.3.1.1(3.7)〕癸-2-基、
1-(3-氯苯基)-1H-四唑-5-基、
吡啶基、
哒嗪基,
条件是,如果A为(d)、(e)、(f)段所述的基团,则Z为CR7R8;如果A为(a)段所述的基团,则Z为S、SO或SO2
本发明还提供具有如上所限定的式(1)的新化合物,但不包括下列例外化合物:
1)其中X和Y都为CH,R1至R4中,R3为Cl,其余为H,而A为苯基、4-氯苯基、或4-氟苯基的化合物;
2)其中X和Y都为CH,R1至R4为氢,或R1、R3和R4为H而R2为F,R5为CH3,而Z为O的化合物;
3)其中A为取代的苯基,R1至R4都为H,或R1至R4中R2为NO2,其余为H的化合物;
4)7-氯-4-〔3-(三氟甲基)苯氧基〕喹啉;
5)6-氟-2-甲基-4-〔2-硝基-4-(三氟甲基)苯氧基〕喹啉;
6)7-氯-4-(4-氯-3,5-二甲基苯氧基)喹啉;
7)7-氯-4-(4-氯-3-甲基苯氧基)喹啉;
8)5-氯-4-〔2,6-二硝基-4-(三氟甲基)苯氧基〕-2,8-二甲基喹啉;
9)8-氯-2-甲基-4-〔2-硝基-4-(三氟甲基)苯氧基〕喹啉;
10)其中Z为NR6的化合物。
本发明的杀真菌结合物至少含有1%重量的式(1)化合物、或式(1)化合物的酸加成盐、或Y为CH的式(1)化合物的N-氧化物,与第二种杀真菌化合物相结合。
本发明的杀真菌组合物含有与一种植物学上可接受的载体相结合的式(1)化合物、或式(1)化合物的酸加成盐、或Y为CH的式(1)化合物的N-氧化物。
在本文中,所有温度都以摄氏度给出,所有百分比都为重量百分比,除非另有说明。
术语“卤素”在单独使用或与其它术语如烷基或烷氧基结合使用时是指F、Cl或Br。
术语“(C1-C4)烷基”指直链烷基。
术语“支链(C2-C4)烷基”指除直链异构体外所有含指定碳原子数的烷基异构体。
术语“(C1-C4)烷氧基”指直链或支链烷氧基。
术语“卤代(C1-C4)烷基”指被一个或多个卤原子取代的直链或支链(C1-C4)烷基。
术语“卤代(C1-C4)烷氧基”指被一个或多个卤原子取代的(C1-C4)烷氧基。
术语“卤代(C1-C4)烷硫基”指被一个或多个卤原子取代的直链或支链(C1-C4)烷硫基。
术语“(C1-C4)酰基”指直链或支链酰基。
术语“取代的苯基”指被至多三个基团取代的苯基,取代基选自卤素、I、(C1-C10)烷基、支链(C3-C6)烷基、卤代(C1-C4)烷基、羟基(C1-C4)烷基、(C1-C4)烷氧基、卤代(C1-C4)烷氧基、苯氧基、苯基、NO2、OH、CN、(C1-C4)链烷酰氧基、或苄氧基。
术语“取代的苯氧基”指被至三个基团取代的苯氧基,取代基选自卤素、I、(C1-C10)烷基、支链(C3-C6)烷基、卤代(C1-C4)烷基、羟基(C1-C4)烷基、(C1-C4)烷氧基、卤代(C1-C4)烷氧基、苯氧基、苯基、NO2、OH、CN、(C1-C4)链烷酰氧基、或苄氧基。
术语“取代的苯硫基”指被至多三个基团取代的苯硫基,取代基选自卤素、I、(C1-C10)烷基、支链(C3-C6)烷基、卤代(C1-C4)烷基、羟基(C1-C4)烷基、(C1-C4)烷氧基、卤代(C1-C4)烷氧基、苯氧基、苯基、NO2、OH、CN、(C1-C4)链烷酰氧基、或苄氧基。
术语“取代的苯磺酰基”指被至多三个基团取代的苯磺酰基,取代基选自卤素、I、(C1-C10)烷基、支链(C3-C6)烷基、卤代(C1-C4)烷基、羟基(C1-C4)烷基、(C1-C4)烷氧基、卤代(C1-C4)烷氧基、苯氧基、苯基、NO2、OH、CN、(C1-C4)链烷酰氧基、或苄氧基。
术语“不饱和碳氢链”指含有1至3个重键部位的碳氢链。
术语“碳环”指含4至7个碳原子的饱和或不饱和环。
“HPLC”指高效液相色谱法。
化    合    物
虽然本发明的所有化合物都是有效的杀真菌剂,但其中某些类型的化合物由于效力较强或易于合成而为优选类型,即:
1)式(1)化合物,其中在R1至R4中至少有两个为H;
2)优选的1)类化合物,其中R1至R4中有三个为氢,一个不为氢;
3)优选的2)类化合物,其中在R1至R4中,R3为Cl,其余为H;
4)优选的2)类化合物,其中在R1至R4中,R4为Cl,其余为H;
5)优选的1)类化合物,其中在R1至R4中,R1和R3都为Cl或都为CH3,其余为H;
5a)优选的5)类化合物,其中A为未取代的苯基;
6)式(1)化合物,其中A为取代的苯基;
7)优选的6)类化合物,其中R11为F;
8)优选的6)类化合物,其中A为邻位由吸电子基团取代的苯基。
9)优选的8)类化合物,其中R9为卤素、CF3、CN、或NO2;
10)式(1)化合物,其中X和Y为CH,Z为O(即4-喹啉基醚类);
11)优选的10)类化合物,其中在R1至R4中,R3为Cl,其余为H(即7-氯-4-喹啉基醚类);
12)优选的10)类化合物,其中在R1至R4中,R3为Br,其余为H(即7-溴-4-喹啉基醚类);
13)优选的10)类化合物,其中在R1至R4中,R1和R3为Cl,其余为H(即5,7-二氯-4-喹啉基醚类);
14)优选的10)类化合物,其中在R1至R4中,R4为Cl,其余为H(即8-氯-4-喹啉基醚类);
15)优选的10)类化合物,其中A为4-氟苯基;
16)式(1)化合物,其中X为CH,Y为N,Z为O(即4-喹唑啉基醚类);
17)优选的16)类化合物,其中在R1至R4中,R3为Cl,其余为H(即7-氯-4-喹唑啉基醚类);
18)优选的16)类化合物,其中在R1至R4中,R3为Br,其余为H(即7-溴-4-喹唑啉基醚类);
19)优选的16)类化合物,其中在R1至R4中,R1和R3都为Cl或都为CH3,其余为H(即5,7-二氯-4-喹唑啉基醚类和5,7-二甲基-4-喹唑啉基醚类);
20)优选的16)类化合物,其中在R1至R4中,R4为Cl,其余为H(即8-氯-4-喹唑啉基醚类);
21)优选的16)类化合物,其中A为4-氟苯基;
22)优选的10)类化合物,其中A为邻位由吸电子基团取代的苯基;
23)优选的16)类化合物,其中A为邻位由吸电子基团取代的苯基。
对白粉病的治疗性和预防性控制来说,特别优选的是其中的X和Y为CH、Z为O、R3为Cl的式(1)化合物(即7-氯-4-喹啉基醚类化合物),这类化合物中最为优选的是7-氯-4-(4-氟苯氧基)喹啉(此化合物本身并未请求保护,但包括在请求保护的方法和组合物中)、7-氯-4-(2-硝基苯氧基)喹啉、4-(2-溴苯氧基)-7-氯喹啉、7-氯-4-(2-氯苯氧基)喹啉、2-〔(7-氯-4-喹啉基)氧〕苄腈、7-氯-4-(2,4-二氟苯氧基)喹啉、7-氯-4-(2-氰基苯氧基)喹啉及7-氯-4-〔2-(三氟甲基)苯氧基〕喹啉。
对白粉病的预防性控制及某种治疗性控制来说,特别优选的是其中的X和Y为CH、Z为O、R1和R3为Cl或CH3的式(1)化合物(即5,7-二氯-4-喹啉基醚类和5,7-二甲基-4-喹啉基醚类)。这类化合物中最为优选的是5,7-二氯-4-(4-氟苯氧基)喹啉、5,7-二氯-4-(4-氟苯氧基)喹啉盐酸盐、5,7-二氯-4-(苯氧基)喹啉、5,7-二氯-4-(4-氟苯氧基)喹啉-1-氧化物。
对控制白粉病来说优选的另一个化合物是7-氯-4-〔(4-氟苯基)甲基〕喹啉。
就抗葡萄孢霉的活性而言,特别优选的是其中的X和Y为CH、Z为O、R4为Cl的式(1)化合物(即8-氯-4-喹啉基醚类)。这类化合物中最为优选的是8-氯-4-(2-氯苯氧基)喹啉、8-氯-4-(2-氯-4-氟苯氧基)喹啉及4-(2-溴苯氧基)-8-氯喹啉。
虽然已提到白粉菌和葡萄孢霉具有特殊意义,但以下所给出的数据将证实本发明化合物同样可控制许多其它植物病原体。
合    成
利用熟知的化学方法来合成本发明的化合物。所需的原料可从市场上购得或易于用标准方法来合成。
Z为O的化合物的合成
Z为O的式(1)化合物可通过使式(7)化合物与式(8)化合物缩合来制备。
Figure 891004726_IMG19
其中R1至R4如前面所限定,
其中A如前面所限定。
该反应可以净相进行,反应温度在80-150℃范围内,最好在130至140℃范围内。一般用过量的式(8)化合物,例如二倍过量。反应时间一般为2至48小时。接着用乙酸乙酯稀释反应混合物,用NaOH水溶液洗涤而除去起始式(8)化合物。用MgSO4干燥有机层,减压除去溶剂得到产物。
一种优选方法是,使式(7)的氯化物与1.2至1.4当量的式(8)原料在二甲苯中回流反应过夜。
Z为S的化合物的合成
Z为S的式(1)化合物可以利用与制备Z为O的化合物相同的方法,通过如上所述的式(7)化合物与式(9)化合物反应来制备。
其中A如前面所限定。也可以将这两种反应物在80至150℃下在DMF中与氢化钠一起搅拌。
Z为SO或SO2的化合物的合成
Z为SO或SO2的式(1)化合物可利用常规氧化法由Z为S的式(1)化合物制备。例如,Z为SO的式(1)化合物可以利用一当量的间氯过氧苯甲酸对硫原子进行氧化来制备,反应于0°至25℃在CH2Cl2中进行。同样,Z为SO2的式(1)化合物可利用2.2当量的间氯过氧苯甲酸对硫原子进行氧化来制备,反应于0°至25℃在合适的溶剂中进行。
此外,Z为SO2的式(1)化合物也可以通过如上所限定的式(7)化合物与如下式的亚磺酸盐反应来制备。
式中M为金属离子,如Na+、Li+、或K+,A如前所述。反应一般在100℃下,在偶极非质子性溶剂如DMF中进行。
Z为NR6的化合物的合成
Z为NR6的式(1)化合物通过式(7)化合物与式(11)的胺缩合来制备。
Figure 891004726_IMG20
式中
R6′为H或(C1-C4)烷基。
A如前面所限定。
使式(7)的氯化物在升高的温度下(100-140℃)与式(11)的胺反应。用一当量的氢化钠来增强亲核反应。R6为(C1-C4)酰基的化合物由R6=H的胺与诸如酰氯或酸酐等酰化剂反应而制备,反应于0-25℃下在碱性介质中进行1-3小时。
Z为CR7R8的化合物的合成
Z为CR7R8的式(1)化合物可以利用Cutler等人所述的方法(R.Cutler et al.,J.Am.Chem.Soc.71,3375,1949)来制备。
该方法是使合适的苯乙腈的钠盐与4,7-二氯喹啉在苯中回流反应。然后将所得的二芳基取代的乙腈溶于预先用无水HCl饱和的正丁醇中,将所得混合物回流1-18小时。真空浓缩冷却的反应混合物,残渣用乙酸乙酯稀释并用NaOH水溶液洗涤。用MgSO4干燥有机层,减压除去溶剂得所需化合物。
衍    生    物
式(1)化合物的N-氧化物通过式(1)化合物与诸如3-氯过氧苯甲酸或过氧化氢等氧化剂反应来制备,反应于-20℃至室温,最好于约0℃在无反应性有机溶剂如二氯甲烷或氯仿中进行。
式(1)化合物的酸加成盐以通常方式获得。
本发明还提供一种制备式(1)化合物的方法,该方法包括:
(a)使式(7)化合物与式(8)化合物缩合生成Z为O的式(1)化合物,
Figure 891004726_IMG21
其中R1至R4如式(1)中所限定,
其中A如式(1)中所限定,或
(b)使如上所限定的式(7)化合物与式(9)化合物缩合生成Z为S的式(1)化合物,
式中A如式(1)中所限定,或
(c)利用常规方法氧化Z为S的式(1)化合物生成Z为SO的式(1)化合物,或
(d)利用常规方法氧化Z为S的式(1)化合物生成Z为SO2的式(1)化合物,或
(e)使式(11)化合物缩合生成Z为NR6′的式(1)化合物,
式中R6′为H或(C1-C4)烷基,A如式(1)中所限定,或
(f)使Z为NR6′的式(1)化合物酰化生成Z为其中R6为(C1-C4)酰基的NR6的式(1)化合物,或
(g)使如上所限定的式(7)化合物与式(12)的取代乙腈的钠盐反应
式中R9至R13如式(1)中所限定,
接着进行酸催化的脱氰基反应,生成一种式(1)化合物,其中的-Z-A为
Figure 891004726_IMG24
(h)氧化Y为CH的式(1)化合物生成相应的N-氧化物。
起    始    原    料
式(8)的苯酚起始原料可从市场上购得,也可以由相应的苯胺通过布赫尔反应来合成,它是使苯胺与亚硫酸氢钠反应进行的(Ang.Chem.Int.Ed.Eng.6,307,1967)。
对邻羟基三氟甲苯来说,优选的制备方法是使邻氯三氟甲苯与苄醇钠反应,然后将所得的醚氢解生成所需产物。
式(9)的硫酚起始原料同样可从市场购得或用常规方法来合成。
喹啉起始原料的制备
喹啉起始原料可利用多种已知方法来合成。
曾有文献给出制备4,7-二氯喹啉和其它多取代喹啉的方法(Organic    Syntheses,Collective    Volume    3,1955,272-75)。也有文献描述了另一种一般方法(Tetrahedron41,3033-36,1985)。
以下实例中所用的许多喹啉起始原料都是如下列反应图示制备的。
Figure 891004726_IMG25
如果得到的产物是异构体混合物,则将各种取代4-喹啉的混合物在标准条件下进行氯化,然后利用液相层析分离4-氯喹啉异构体。
4,5-二氯喹啉是通过下述方法制备的,即使3-氯苯胺与丙烯酸于室温下在水中反应两天。然后分离粗产物,将其溶于过量的多磷酸加热至100℃,从而得到5-和7-氯四氢喹啉-4-酮的混合物。用色谱法分离出5-氯类似物,随后在热冰乙酸中用碘处理,得到4-羟基-5-氯喹啉,将其卤化即得到所需的中间体。参见法国专利1514280。
其它4-氯-5-取代喹啉的制备方法是:将相应的5-取代喹啉转变为N-氧化物,将其氯化,然后利用HPLC分离所得的4-氯和2-氯异构体的混合物。
5-氟和5-溴喹啉可利用相同的一般方法来制备(J.A.C.S.,71,1785,1949)。溴喹啉可以接着进行锂化,并用适当的亲电子试剂在低温下骤冷而生成其它5-取代喹啉。参见Chem.Ber.,696:98,1966)。
硝基喹啉类化合物的制备已有公开(J.A.C.S.,68:1267,1946)。4-氯喹啉进行硝基化可以较为纯净地得到5-和8-硝基-4-氯喹啉的混合物,该混合物可利用液相色谱法来分离。6-和7-硝基化合物可通过合适的硝基喹啉-3-羧酸的银盐进行脱羧反应来制备。
噌啉起始原料的制备
噌啉类似物利用已报道的方法来制备(C.M.Atkinson    and    J.C.Simpson    J.Chem.Soc.London,232,1947)。利用亚硝酸钠和无机酸使取代的2-氨基苯乙酮于0-5℃在水中进行重氮化,重氮盐中间体与上述酮的烯醇成分反应生成所需的4-羟基噌啉。用常规方法进行氯化即生成所需的中间体。
喹唑啉起始原料的制备
喹唑啉起始原料也可从市场上购得,也可以利用已报导的方法来制备。例如,可以利用市售氨茴酸类化合物作起始原料来合成喹唑啉类。一种有效的方法是通过氨茴酸与过量甲酰胺在回流下进行缩合来合成4-羟基喹唑啉(M.Endicott    et    al.,J.Am.Chem.Soc.,68:1299,1946)。羟基喹啉也可以利用Gold氏试剂在二噁烷中回流来进行制备(J.Gupton;Correia,K.;Hertel,G.Synthetic    Communications,14:1013,1984)。得到4-羟基喹唑啉后,如上述进行卤化。
实    例
下列实例为实际上由上述一般方法制备的化合物。每个化合物均给出了熔点。表格后描述了某些化合物的具体的说明性制备方法,这些化合物为实例2、19、21、28、31、35、114和116的化合物。
表1
4-(芳氧基)喹啉类
实施例号    化合物    M.P.
17-氯-4-〔3-(三氟甲基) 96-97℃
苯氧基〕喹啉
27-氯-4-(4-氟苯氧基)喹 94℃
37-氯-4-(4-氯苯氧基)喹 82℃
4    2-〔(7-氯-4-喹啉基)    122-123℃
氧〕苄腈
57-氯-4-苯氧基喹啉 44-46℃
67-氯-4-(4-氟苯氧基)喹 164-165℃
啉,
1-氧化物
7    7-氯-4-(3-氯苯氧基)喹    99-101℃
8    4-(2-溴苯氧基)-7-氯喹    71-73℃
9    7-氯-4-(2,4-二氟苯氧    116-118℃
基)喹啉
10    7-氯-4-(2,3,5,6-    121-123℃
四氟苯氧基)喹啉
11    4-(4-氟苯氧基)-6-甲基    62-63℃
喹啉
12    7-氟-4-(4-氟苯氧基)    76-77℃
喹啉
13    7-氯-4-(3-吡啶氧基)喹    105-107℃
14    7-氯-4-(2-氯苯氧基)喹    69-70℃
15    7-氯-4-(1-萘氧基)喹啉    73-76℃
16    7-氯-4-(2,6-二氟苯氧    134-136℃
基)喹啉
17    4-(4-氟苯氧基)-6-甲氧    100-103℃
基喹啉
18    5,7-二氯-4-(4-氟苯氧    139-140℃
基)喹啉,1-氧化物
19    7-氯-4-(2-氯-4-氟苯    177-178℃
氧基)喹啉,1-氧化物
20    5,7-二氯-4-(4-氟苯氧    213-220℃
基)喹啉
21    7-氯-4-(4-氟苯氧基)喹    221-224℃
啉,盐酸盐
22    8-溴-4-(2-氯苯氧基)喹    68-71℃
23    7-氯-4-〔2-(异丙基)苯    油状物
氧基〕喹啉
24    4-(4-氟苯氧基)-5,7-    92-94℃
二甲基喹啉
25    7-氯-4-(五氟苯氧基)喹    95℃
26    4-(4-氟苯氧基)-8-甲    油状物
基喹啉
27    7-氯-4-(3-氯-4-氟    124-127℃
苯氧基)喹啉
28    5,7-二氯-4-(4-氟苯    82℃
氧基)喹啉
29    7-氯-4-(4-苯氧基苯氧    54-55℃
基)喹啉
30    7-氯-4-〔4-(叔丁基)    144-145℃
苯氧基〕喹啉
31    8-氯-4-(2-氯苯氧基)    56-58℃
喹啉
32    8-氯-4-〔2-(三氟甲基)    64-66℃
苯氧基〕喹啉
33    4-(2-溴苯氧基)-8-氯    70-72℃
喹啉
34    8-氯-4-(2-氟苯氧基)喹    60-62℃
35    8-氯-4-(2-氯-4-氟苯    99-101℃
氧基)喹啉
36    5,7-二氯-4-(2,4-二    110-111℃氟苯氧基)喹啉
37    5,7-二氯-4-(2-硝基苯    84-86℃
氧基)喹啉
38    5,7-二氯-4-〔2-(三氟    86-89℃
甲基)苯氧基〕喹啉
39    5,8-二氯-4-(2,4-二    102-103℃
氟苯氧基)喹啉
40    5,8-二氯-4-(4-氟苯氧    114-115℃
基)喹啉
41    6,7-二氯-4-〔2-(三氟    146-148℃
甲基)苯氧基〕喹啉
42    4-(2-氯-4-氟苯氧基)-    126-128℃
8-硝基喹啉
43    8-氯-4-(4-氟苯氧基)-    105-106℃
5-甲基喹啉
44    7-乙氧基-4-(4-氟苯氧    93-95℃
基)喹啉
45    6-乙氧基-4-(4-氟苯氧    99-102℃
基)喹啉
46    7-氯-4-〔4-(异丙基)苯    52-55℃
氧基〕喹啉
47    6-溴-8-氯-4-(4-氟苯    136-138℃
氧基)喹啉
48    6-溴-8-氯-4-(2-氯-    130-132℃
4-氟苯氧基)喹啉
49    8-氯-4-〔4-(异丙基)苯    101-103℃
氧基〕喹啉
50    7-乙基-4-(4-氟苯氧基)    油状物
喹啉
51    7-氯-4-(3-氟苯氧基)喹    71-73℃
52    7-氯-4-(2-氟苯氧基)喹    72-73℃
53    7-氯-4-(4-甲基苯氧基)    78-80℃
喹啉
54    7-氯-4-(4-甲氧基苯氧    88-90℃
基)喹啉
55    7-氯-4-(2-甲氧基苯氧    81-83℃
基)喹啉
56    7-氯-4-(2-甲基苯氧基)    48-50℃
喹啉
57    7-氯-4-(3-硝基苯氧基)    149-151℃
喹啉
58    7-氯-4-(2-硝基苯氧基)    113-115℃
喹啉
59    7-氯-4-(4-硝基苯氧基)    157-159℃
喹啉
60    7-氯-4-〔2-(三氟甲基)    59-61℃苯氧基〕喹啉
61    7-氯-4-〔4-(三氟甲基)    81-82℃
苯氧基〕喹啉
62    4-(2-溴-4-氟苯氧基)-    100-102℃
7-氯喹啉
63    8-氯-4-(2,4-二氯苯氧    165-167℃
基)喹啉
64    8-氯-4-(2-氰基苯氧基)    119-121℃
喹啉
65    8-氯-4-(2,6-二氯-4    161-162℃
-氟苯基)喹啉
66    7-硝基-4-(2-三氟甲基苯    110-111℃
氧基)喹啉
67    8-氯-4-(2-碘苯氧基)喹    油状物
68    7-氯-4-(2,6-二溴-4    128-130℃
-氟苯氧基)喹啉
69    4-(4-氟苯氧基)喹啉    68-69℃
70    7-氯-4-〔3-(叔丁基)苯    油状物
氧基〕喹啉
71    7-氯-4-〔2-(叔丁基)苯    90-92℃
氧基〕喹啉
72    4-〔(7-氯-4-喹啉基)    211-213℃
氧〕苯酚
73    2-〔(7-氯-4-喹啉基)    209-211℃
氧〕苯酚
74    4-〔(1,1′-联苯)-2-    油状物
基氧)-7-氯喹啉
75    7-氯-4-(2-氯-4-氟苯    86-89℃
氧基)喹啉
76    7-氯-4-(2-碘苯氧基)喹    68-70℃
77    6-氯-4-(4-氟苯氧基)喹    98-100℃
78    8-氟-4-(4-氟苯氧基)喹    85-87℃
79    4-(4-氟苯氧基)-5,7-    87-89℃
二甲氧基喹啉
80    4-(4-氟苯氧基)-6-硝基    176-178℃
喹啉
81    4-(2-氯苯氧基)-8-硝基    115-117℃
喹啉
82    4-(4-氟苯氧基)-5-硝基    132-134℃
喹啉
83    7-氯-(4-氟-2-硝基苯氧    148-151℃
基)喹啉
84    5-氟-4-(4-氟苯氧基)喹    91-93℃
85    7-溴-4-(4-氟苯氧基)喹    87-89℃
86    7-氯-6-氟-4-(4-氟苯    143-145℃
氧基)喹啉
87    5-氯-4-(4-氟苯氧基)-    110-112℃
6-甲基喹啉
88    5-氯-6-氟-4-(4-氟苯    117-118℃
氧基)喹啉
89    5-溴-4-(4-氟苯氧基)喹    72-74℃
90    7-溴-4-(2,4-二氟苯氧    110-112℃
基)喹啉
91    6-氯-4-(4-氟苯氧基)-    117-120℃
8-羟基喹啉
92    5,6-二氯-4-(4-氟苯氧    114-116℃
基)喹啉
93    4-(4-氟苯氧基)-6-甲氧    139-141℃
基-8-硝基喹啉
94    5,7-二氯-4-(2-氟苯氧    99-101℃
基)喹啉
95    5,7-二氯-4-(2-氯苯氧    78-79℃
基)喹啉
96    5,7-二氯-4-(2-氰基苯    88-90℃
氧基)喹啉
97    5,7-二氯-4-(2-氯-4    83-85℃
-氟苯氧基)喹啉
98    8-氯-4-(2,4-二氟苯氧    105-107℃
基)喹啉
99    7,8-二氯-4-(2-氯苯氧    120-121℃
基)喹啉
100    8-氯-4-(3-氯-2-硝基    86-88℃
苯氧基)喹啉
101    4-(2-溴-4-氟苯氧基)-    106-107℃
8-氯喹啉
102    8-氯-4-(3-氯苯氧基)喹    82-84℃
103    7-氯-4-〔4-(三氟甲硫基)    90-91℃
苯氧基〕喹啉
104    8-氯-4-〔4-(三氟甲硫    112-114℃
基)苯氧基〕喹啉
105    4-(4-氟苯氧基)-7-(三    87-88℃
氟甲氧基)喹啉
106    4-(3-氯-4-氟苯氧基)-    87-88℃
8-氯喹啉
107    8-氯-4-(2-甲基苯氧基)    85-87℃
喹啉
108    8-氯-4-(2,6-二氯苯氧    156-159℃
基)喹啉
109    8-氯-4-(2-甲氧基苯氧    120-122℃
基)喹啉
110    8-氯-4-(4-甲氧基苯氧    119-121℃
基)喹啉
111    5-氯-4-(4-氟苯氧基)喹    62-64℃
112    5,7-二氯-6-氟-4-(4    167-169℃
-氟苯氧基)喹啉
本身未请求保护的化合物
表2
4-(苄基)喹啉类
实施例号    化合物    M.P.
113    7-氯-4-〔(4-氟苯基)甲    100-102℃
基〕喹啉
114    7-氯-α-(4-氟苯基)-4    118-120℃
-喹啉乙腈
115    7-氯-4-〔(4-氯苯基)甲    98-101℃
基〕喹啉
表    3
N-苯基-4-喹啉胺类
实施例号    化    合    物    M.P.
1167-氯-N-(4-氟苯基)-4 214-216℃
-喹啉胺
1177-氯-N-(3-氟苯基)-4 203-208℃
-喹啉胺
1187-氯-N-(五氟苯基)-4- 205-207℃
喹啉胺
1197-氯-N-(2-氟苯基)4- 178-179℃
喹啉胺
1207-氯-N-(2,3,4-三氟 214-216℃
苯基)-4-喹啉胺
1212-〔(7-氯-4-喹啉基)氨 208-210℃
基〕-6-氟苄腈
1228-氟-N-(2-氟苯基)-4 158-159℃
-喹啉胺
1237-氯-N-(3,5-二氟苯基) 194-197℃
-4-喹啉胺单水合物
1247-氯-N-(4-氟苯基)-N 83-85℃
-甲基-4-喹啉胺
1258-氯-N-(2-氯苯基)-4 147-149℃
-喹啉胺
本身未请求保护的化合物
表    4
4-芳氧基噌啉类
实施例号    化    合    物    M.P.
126    7-氯-4-(4-氟苯氧基)噌    144-145℃
表    5
4-(苯氧基)喹唑啉类
实施例号    化    合    物    M.P.
127    4-(2-氯苯氧基)喹唑啉    106-108℃
128    4-(2,4-二氯苯氧基)喹唑    122.5-124℃
129    8-氟-4-(4-氟苯氧基)喹    138-140℃
唑啉
130    7-氯-4-(4-氟苯氧基)喹    121-122℃
唑啉
131    4-〔3-(叔丁基)苯氧基〕喹    油状物
唑啉
表    6
其它类化合物
实施例号    化    合    物    M.P.
1326-氟-2-甲基-4-〔2-硝 140℃
基-4-(三氟甲基)苯氧基〕喹
1337-氯-4-(4-氯-3,5-二 102℃
二甲基苯氧基)喹啉
1347-氯-4-(4-氯-3-甲基 85℃
苯氧基)喹啉
1355-氯-4-〔2,6-二硝基- 189℃
4-(三氟甲基)苯氧基〕-2,8
-二甲基喹啉
1368-氯-2-甲基-4-〔2-硝 184℃
基-4-(三氟甲基)苯氧基〕喹
137    7-氯-4-(3-甲基苯氧基)    77-79℃
喹啉
138    4-〔(7-氯-4-喹啉基)氧〕    142-144℃
苄腈
139    3-〔(7-氯-4-喹啉基)氧〕    133-134℃
苄腈
140    4-(4-溴苯氧基)-7-氯喹    82-84℃
141    7-氯-4-(4-碘苯氧基)喹    110-113℃
142    4-(3-溴苯氧基)-7-氯喹    89-91℃
1437-氯-N-苯基-4-喹啉胺 202-204℃
144N-苯基-4-喹啉胺 205-206℃
145    7-氯-4-(4-氟苯氧基)-    123-125℃
6-甲氧基喹啉
146    7-氯-4-(2-甲基-3-吡    181-183℃
唑氧基)喹啉
147    8-氯-4-(2,4-二氯-6    90-92℃
-氟苯氧基)喹啉
148    8-氯-4-(2-乙氧基苯氧    76-78℃
基)喹啉
149    8-氯-4-(4-氟-2-甲基    103-105℃
苯氧基)喹啉
150    7-氯-4-(2-甲基-4-氟    98-100℃
苯氧基)喹啉
151    8-氯-4-(4-氯-2-氟苯    142-144℃
氧基)喹啉
152    7-氯-4-〔4-〔2-(4-    204-206℃
羟基苯基)乙基〕苯氧基〕喹啉
153    3-氯-4-(4-氟苯氧基)喹    65℃
154    6-氯-4-(4-氟苯氧基)-    188-190℃
2-甲基喹啉
155    4-(2-氯苯氧基)-6-氟-    94-96℃
2-甲基喹啉
156    4-(2,6-二溴-4-硝基苯    232-233℃
氧基)-8-氯喹啉
157    4-(4-溴-2-氟苯氧基)-    122-125℃
8-氯喹啉
158    8-氯-4-(2,4-二溴苯氧    115-116℃
基)喹啉
159    8-氯-4-(4-氟-2-硝基    133-135℃
苯氧基)喹啉
160    8-氯-4-(2,4,6-三氯    153-155℃
苯氧基)喹啉
161    7-氯-4-(五氟苯硫基)喹啉    130°(蜡状物)
162    〔4-〔(7-氯-4-喹啉基)    89-91℃
氧〕苯基〕(4-氟苯基)甲酮
163    7-氯-4-(2-吡啶氧基)喹    170-171℃
164    4-〔1-〔4-〔(7-氯-4    224-226℃
-喹啉基)氧〕苯基〕-2,2,2
-三氟-1-(三氟甲基)乙基〕
苯酚
165    7-氯-4-(4-氟苯硫基)喹    140-141℃
166    7-氯-4-(4-氟苯氧基)-    141-142℃
2-甲基喹啉
167    8-氯-4-(2-硝基苯氧基)    142-144℃
喹啉
168    4-(4-氟苯硫基)喹啉    92-94℃
169    5,7-二氯-4-(3-溴苯氧    120-121℃
基)喹啉
170    5,8-二氯-4-(2-硝基苯    120-121℃
氧基)喹啉
171    8-溴-4-(4-氟苯氧基)喹    122-123℃
172    4-(3-甲氧基苯氧基)喹啉    46-48℃
173    4-(3-甲基苯氧基)喹啉    油状物
174    1-(4-氟苯氧基)-8,9-    53-54℃
二氢-7H-环戊二烯并〔F〕喹
175    4-(4-氟苯氧基)-7,8-    78-79℃
二氢-6H-环戊二烯并〔G〕喹
176    4-(4-氟苯氧基)-7-(三氟    78-80℃
氟甲硫基)喹啉
1774-苯氧基-6-硝基喹啉 未得到
178    5,7-二氯-4-(4-氟苯氧    110-112℃
基)-6-甲基喹啉
179    4-(4-氟苯氧基)-7-(甲    87-89℃
硫基)喹啉
180    7-氯-4-(2,4-二硝基苯    181-183℃
氧基)喹啉
181    4-(4-氟苯氧基)-6-氟-    126-128℃
2-甲基喹啉
182    8-氯-4-(2,6-二溴-4    195-197℃
-氟苯氧基)喹啉
183    5-氯-2,8-二甲基-4-(    75-76℃
4-氟苯氧基)喹啉
184    8-氯-4-(3-甲基苯氧基)    46-48℃
喹啉
185    4-(2-氯-4-氟苯氧基)喹    158-160℃
唑啉
186    4-(4-氟苯氧基)-5-甲氧    108-110℃
基-7-三氟甲基喹啉
1874-(2-溴苯基氨基)-8-氯 147-149℃
喹啉
188    7-氯-4-〔2-(甲硫基)苯    107-108℃
氧基〕喹啉
189    7-氯-4-(4-乙氧基苯氧    113-115℃
基)喹啉
190    8-氯-4-(4-乙氧基苯氧    94-96℃
基)喹啉
191    5,7-二氯-4-苯氧基喹啉    97-99℃
192    8-氯-4-(2-氯苯硫基)喹    112-114℃
193    7-氯-4-(3-甲氧基苯氧    69-70℃
基)喹啉
194    8-氯-4-(4-碘苯氧基)喹    114-116℃
195    4-(4-氟苯氧基)-7-硝基    159-161℃
喹啉
196    8-氯-4-(4-氯-2-甲基    143-145℃
苯氧基)喹啉
197    4-(4-氯-3,5-二甲基苯    128-129℃
氧基)-8-氯喹啉
198    4-(4-氯-2-硝基苯氧基)    149-150℃
-8-氯喹啉
199    7-氯-4-(3-哒嗪氧基)喹    158-160℃
200    8-氯-4-(2-乙基苯氧基)    油状物
喹啉
201    7-氯-4-〔(4-氯-1-萘    120-122℃
基)氧〕喹啉
202    8-氯-4-(4-氟苯氧基)噌    160-163℃
203    4-〔(1,1′-联苯)-4-    139-141℃
氧基〕-7-氯喹啉
204    3-〔(7-氯-4-喹啉基)    150-154℃
氧〕苯酚
205    7-氯-4-(2-苯氧基苯氧    84-86℃
基)喹啉
206    4-(4-氟苯氧基)-8-(三    101-102℃
氟甲基)喹啉
207    6,8-二氟-4-(4-氟苯氧    118-119℃
基)喹啉
208    7-氯-4-(1,3-苯并二噁    85-87℃
茂-5-氧基)喹啉
209    8-氯-4-(2-氯苯氧基)喹    127-129℃
唑啉
210    8-氯-4-(2-氯-4-氟苯    172-173℃
氧基)喹唑啉
211    4-(1,3-苯并二噁茂-5-    120-122℃
氧基)-8-氯喹啉
212    8-氯-4-〔2-(甲硫基)苯    67-69℃
氧基〕喹啉
213    8-氯-4-(4-甲基苯氧基)    97-98℃
喹啉
2148-氯-N-(2-氯-4-氟苯 163-165℃
基)-4-喹啉胺
215    8-氯-4-(2,3-二甲基苯    118-120℃
氧基)喹啉
216    8-氯-4-(3,4-二甲基苯    88-90℃
氧基)喹啉
217    4-(2-溴苯氧基)-8-氯喹    115-116℃
唑啉
218    8-氯-4-(2-甲基苯氧基)    100-102℃
喹唑啉
219    7-氯-4-〔4-(三氟甲氧    79-80℃
基)苯氧基〕喹啉
220    8-氯-4-〔4-(三氟甲氧    131-133℃
基)苯氧基〕喹啉
221    8-氯-4-(2,5-二氯苯氧    70-73℃
基)喹啉
222    8-氯-4-(2,6-二甲基苯    125-127℃
氧基)喹啉
223    8-氯-4-(3,5-二甲基苯    85-87℃
氧基)喹啉
224    8-氯-4-(2-氯-6-甲基    154-156℃
苯氧基)喹啉
225    8-氯-4-(2,5-二甲基苯    51-53℃
氧基)喹啉
226    8-氯-4-〔2-氯-5-(三    120-122℃
氟甲基)苯氧基〕喹啉
227    4-(2-氯-4-硝基苯氧基)    179-181℃
-8-氯喹啉
228    8-氯-α-(2-氯苯基)-4    135-137℃
-喹啉乙腈
229    6,8-二氯-4-(4-氟苯氧    136-138℃
基)喹啉
2304-苯氧基喹啉 油状物
231    6,8-二氯-4-(2-氯苯氧    98-100℃
基)喹啉
232    4-(4-氟苯氧基)-8-硝基    128-130℃
喹啉
233    4-(2-氰基苯氧基)-5,6,7    163-165℃
-三氯喹啉
234    5,6,7-三氯-4-(2-氯    182-184℃
-4-氟苯氧基)喹啉
235    4-(2,4-二溴苯氧基)-7    134-136℃
-氯喹啉
236    5,6,7-三氯-4-(4-氟苯    161-163℃
苯氧基)喹啉
237    4-(4-溴-2-氟苯氧基)-    129-131℃
7-氯喹啉
238    7-氯-4-〔三环(3.3.1.1-    136-138℃
(3,7))-癸-2-氧基〕喹
239    8-氯-4-〔〔1-(3-氯苯    148-150℃
基)-1H-四唑-5-基〕氧〕
喹啉
240    8-氯-4-(4-乙基苯氧基)    70-72℃
喹啉
241    4-〔(1,1′-联苯)-2-    得不到
氧基〕喹唑啉
242    7-氯-4-(2,6-二甲基苯    54-56℃
氧基)喹啉
243    7-氯-4-吡唑(氧)喹啉    190-192℃
244    8-氟-4-(2-苯基苯氧基)    未得到
喹啉
245    4-(2-氯-4,6-二氟苯氧    99-101℃
基)-8-氯喹啉
246    7-氯-4-(4-氟苯氧基)-    121-123℃
6-甲基喹啉
247    6,7-二氯-4-(4-氟苯氧    134-136℃
基)喹啉
248    7,8-二氯-4-(4-氟苯氧    144-145℃
基)喹啉
249    2-〔(7,8-二氯-4-喹啉    153-154℃
基)氧〕苄腈
250    2-氯-4-(4-氟苯氧基)喹    142-144℃
251    7,8-二氯-4-(2,4-二    153-154℃
氟苯氧基)喹啉
252    7,8-二氯-4-(2-氟苯氧    143-145℃
基)喹啉
2532-甲基-4-苯氧基喹啉 71-72℃
254    8-氯-4-〔(1-甲基环戊基)    82-83℃
氧〕喹啉
255    5,6,7,8-四氯-4-(4    未得到
-氟苯氧基喹啉
256    4-〔(5,7-二氯-4-喹啉    161-163℃
基)氧〕苄腈
257    7-氯-4-(甲硫基)喹啉    102-104℃
258    3-溴-7-氯-4-(2,4-    113-114℃
二氟苯氧基)喹啉
259    3-溴-7-氯-4-(4-氟苯    96.5-98℃
氧基)喹啉
260    3-溴-4-(2-氯-4-氟苯    140-141℃
氧基)-7-氯喹啉
261    3-溴-4-(2-氯苯氧基)-    146-148℃
7-氯喹啉
262    3-溴-4-(2-溴-4-氟苯    152-154℃
氧基)-7-氯喹啉
263    7-氯-4-(甲磺酰基)喹啉    164-166℃
264    8-氯-4-(甲磺酰基)喹啉    98-100℃
265    3-溴-7-氯-4-(甲磺酰基)    140-142℃
喹啉
本身未请求保护的化合物
以下详细描述的用来制备选定实施例的方法为用来制备其它实施例化合物的代表性方法。
实施例2和21
7-氯-4-(4-氟苯氧基)喹啉和7-
氯-4-(4-氟苯氧基)喹啉,盐酸盐
将含有7.92克(0.04摩尔)4,7-二氯喹啉、4.48克(0.04摩尔)4-氟苯酚和24毫升二甲苯的浆状物搅拌并加热至回流。将所得的橙色透明溶液于144℃下回流17小时,此时再加入0.90克(0.008摩尔)4-氟苯酚,并继续回流。将该混合物浓缩成棕色固体,将该固体溶于CH2Cl2(50毫升)和1N NaOH(50毫升)的混合液中。有机层用50毫升1N NaOH洗四次,然后用Na2SO4干燥,浓缩成棕色油状物(9.8克)后进行结晶。该产物为7-氯-4-(4-氟苯氧基)喹啉,用己烷重结晶后得到白色结晶固体。
产率:8.01克(73.2%)。M.P.91-92℃
利用类似的方法制备相应的胺盐酸盐,不同的是,反应混合物回流18小时后,将该混合物冷却至室温,并用半小时时间通入无水HCl。然后将该混合物冷却至0℃并于0℃下放置2小时。然后过滤该混合物,产物于40℃进行真空干燥。滤液于室温下搅拌48小时,在此期间又沉淀出一些产物。该产物为7-氯-4-(4-氟苯氧基)喹啉盐酸盐,用40毫升丙醇重结晶。
产率:9.10克(73%)。M.P.220-224℃。
实施例19
7-氯-4-(2-氯-4-氟苯氧基)喹啉,1-氧化物
于0℃下,将5.0克(16.22毫摩尔)4-(2-氯-4-氟苯氧基)-7-氯喹啉、4.20克(19.47毫摩尔)80%3-氯过氧苯甲酸和50毫升CH2Cl2的混合物搅拌6小时。减压除去CH2Cl2,将残余物溶于乙酸乙酯中,用碱洗涤。有机层减压除去溶剂后,形成白色固体。将其用乙酸乙酯重结晶。
产率3.04克(58%)。M.P.177-178℃。
元素分析:
理论值:    C,55.58;H,2.49;N,4.32;
实测值:    C,55.67;H,2.46;N,4.43.
实施例28
5,7-二氯-4-(4-氟苯氧基)喹啉
将29.11克4,5,7-三氯喹啉和16.84克4-氟苯酚的混合物加热至160℃。大约40分钟后,此熔融的溶液固化。将该固体溶于乙酸乙酯和2N    NaOH中。用碱洗涤有机层以除去过量的苯酚,然后进行干燥。减压除去溶剂,残渣通过用庚烷重结晶而纯化,得到29.49克标题产物。M.P.105-106℃。
元素分析:
理论值:    C,58.47;H,2.62;N,4.55;
实测值:    C,58.38;H,2.52;N,4.55.
实施例31
8-氯-4-(2-氯苯氧基)喹啉
将2.0克4,8-二氯喹啉和2.6克2-氯苯酚的混合物加热至160℃并进行搅拌。利用TLC监测反应进程。当不再剩有4,8-二氯喹啉时,用乙酸乙酯稀释反应混合物,用碱洗涤除去大部分过量苯酚。为除去洗涤后残留的苯酚,利用HPLC来纯化产物。合并含产物的部分并减压除去溶剂。将油状产物进行结晶。产率:1.36克(46%)。M.P.56-58℃。
元素分析:
理论值:    C,62.09;H,3.13;N,4.83;
实测值:    C,62.14;H,3.11;N,5.04.
实施例35
8-氯-4-(2-氯-4-氟苯氧基)喹啉
将2.0克4,8-二氯喹啉和2.96克2-氯-4-氟苯酚的混合物加热至160℃并进行搅拌。利用TLC监测反应进程。当不再剩有4,8-二氯喹啉时,用碱洗涤产物除去苯酚,然后利用HPLC纯化之。所得的棕色固体用庚烷重结晶,得1.54克标题产物,为黄色结晶。产率:49%。M.P.99-101℃。
元素分析:
理论值:    C,58.47;H,2.62;N,4.55;
实测值:    C,58.39;H,2.85;N,4.49.
实施例114
7-氯-α-〔(4-氟苯基)甲基〕喹啉
将100克(740毫摩尔)4-氟苯基乙腈在200毫升苯中的溶液加至冷却的(0℃)40克(945毫摩尔)氨基钠在600毫升苯中的浆状物中。加完后,将溶液温热至室温并搅拌半小时。再将反应混合物冷却到0℃,以逐渐增加的量加入73.2克(370毫摩尔)固体二氯喹啉,然后于环境温度下将该混合物搅拌过夜。用NH4Cl停止反应后进行后处理,得到二取代乙腈粗品,将其溶于500毫升用无水HCl饱和的正丁醇中。将此酸性溶液加热回流18小时。蒸馏除去大部分溶剂,残渣用溶剂稀释并用10%NaOH洗涤。干燥有机层并真空除去溶剂。利用HPLC进行纯化,得67克标题产物。产率:67%
实施例116
7-氯-N-(4-氟苯基)-4-喹啉胺
向2.0克4,7-二氯喹啉中加入2.24克4-氟苯胺,将该混合物搅拌加热至160℃。在此温度下几分钟后,该混合物即发烟,熔融物固化。使该固体冷却,然后溶解于乙酸乙酯中并洗去苯胺。用MgSO4干燥有机层,然后减压除去溶剂。残渣用庚烷重结晶,得1.27克7-氯-N-(4-氟苯基)-4-喹啉胺。M.P.214-216℃。(产率为46.1%)。
元素分析:
理论值:    C,66.07;H,3.70;N,10.27;
实测值:    C,66.34;H,3.83;N,10.56.
应    用
业已发现式(1)化合物能够控制真菌特别是植物病原体。这些化合物在用于治疗植物的真菌病时,是将它们以抑制病害且植物学上可接受的量应用于植物的。这里所用的术语“抑制病害且植物学上可接受的量”,是指杀死或抑制需要控制的植物病害,但对植物没有明显毒性的本发明化合物的量。这个量一般约为1-1000ppm,最好为10-500ppm。所需化合物的确切浓度随所要防治的真菌病、所采用的剂型、施用方法、特定的植物种属及气候条件等因素的不同而不同。本发明化合物也可以用来保护贮存谷物和其它非植物场所免受真菌侵染。
温    室    试    验
在实验室中进行下列实验以测定本发明化合物的杀真菌效力。
试验1
此筛选试验用来评价本发明化合物对各种不同的植物病原生物的效力。
施用时,将50毫克化合物溶于1.25毫升溶剂中配制出试验化合物。该溶剂是由50毫升“吐温20”(聚氧乙烯(20)山梨糖醇单月桂酸酯表面活性剂)与475毫升丙酮和475毫升乙醇混合而制得的。用去离子水将溶剂/化合物溶液稀释至125毫升。所得制剂含有400ppm试验化合物。用溶剂一表面活性剂混合液进行逐级稀释得到更低的浓度。
配制的试验化合物以叶片喷雾方式施用。采用如下植物病原体及其相应的植物。病原体    在下列各表中的代号    宿主
Erysiphe    graminis    tritici    POWD    小麦
小麦白粉病    MDEW
Pvricularia    oryzae    RICE    稻
稻瘟病    BLAS
Puccinia    recondita    tritici    LEAF    小麦
叶锈病    RUST
Botrytis    cinerea    GRAY    葡萄浆果
灰绿葡萄孢    MOLD
Pseudoperonospora    cubensis    DOWN    南瓜
瓜类假霜霉    MDEW
Cercospora    beticola    LEAF    甜菜
甜菜褐斑病尾孢霉    SPOT
Venturia    inaequalis    APPL    苹果籽苗
苹果黑星病    SCAB
Septoria    tritici    LEAF    小麦
小麦叶枯病壳针孢霉    BLOT
将所配制的试验化合物喷到宿主植物的所有叶片表面(或摘下的浆果)上,直至出现径流。将分别栽有一种宿主植物的单个花盆放在支在通风室中的旋转轴架上。将试验溶液喷在所有叶片表面。待所有处理溶液都干燥后,在2-4小时内用适当的病原体对植物进行接种。
试验化合物控制病害的效力用下列等级进行分级:
0=未对特定病原生物进行测试
-=在400ppm时有0-19%控制
+=在400ppm时有20-89%控制
++=在400ppm时有90-100%控制
+++=在100ppm时有90-100%控制
结果示于表7:
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
1    +    -    -    -    -    -    -    +
2    +++    -    -    -    +    0    -    +
3    ++    -    -    -    +    0    -    +
4    +++    -    -    -    -    -    -    -
5    ++    +    +    -    -    +    -    -
6    +++    -    +    -    +    ++    -    +
7    ++    -    -    -    -    -    -    -
8    +++    -    -    -    +    -    -    +
9    +++    -    -    -    -    +    -    -
10    +    -    +    -    +    +    -    +
11    +    +    ++    -    ++    -    +    +
12    +    -    +    -    ++    -    -    -
13    +    -    ++    -    +    -    +    -
14    +++    -    +    -    -    -    -    -
15    ++    +    -    -    ++    +    -    -
16    ++    -    -    -    +    -    -    -
17    +++    +    ++    -    +    -    -    -
18    +++    +    -    -    -    +    -    -
19    ++    -    -    -    ++    +    -    +
20    +++    -    -    -    +    0    0    0
21    +++    -    -    -    -    0    0    0
22    +++    ++    -    ++    ++    0    0    0
23    ++    ++    -    +    +    0    0    0
24    +++    ++    ++    -    -    0    0    0
25    +    -    -    -    -    -    -    -
26    +    -    +    -    +    -    -    -
27    +    -    -    -    -    0    0    0
28    +++    -    +    -    -    +    -    -
29    +++    +    -    -    +    -    -    -
30    +    -    +    -    -    0    0    0
31    +    ++    +    +++    ++    +    +++    -
32    +    +    -    -    -    -    -    +
33    +    +    -    +++    +    -    +    -
34    +    -    -    +    -    0    0    0
35    +    -    +    +++    +    -    +++    +
36    +++    -    -    -    -    0    0    0
37    +    +    -    -    ++    0    0    0
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
38    ++    +    -    -    -    0    0    0
39    +++    +    -    -    -    -    -    -
40    ++    +    -    -    -    -    -    -
41    ++    -    -    -    -    0    0    0
42    -    -    -    +    -    0    0    0
43    ++    -    -    -    -    0    0    0
44    +    +    +    -    -    0    0    0
45    +    -    -    -    +    0    0    0
46    +    -    -    -    -    0    0    0
47    -    -    -    -    +    0    0    0
48    ++    -    -    -    -    0    0    0
49    -    -    -    +    -    0    0    0
50    ++    -    ++    -    ++    0    0    0
51    ++    +    -    -    -    -    -    +
52    +++    -    -    -    -    +    -    +
53    +    -    -    -    -    0    0    0
54    ++    -    +    -    +    -    -    -
55    +    -    +    -    ++    -    +    -
56    +    +    -    -    +    -    -    -
57    +    -    -    -    -    -    -    -
58    ++    -    -    -    -    -    -    +
59    ++    +    -    -    -    -    -    -
60    +++    +    -    -    +    -    -    -
61    +    -    -    -    +    0    0    0
62    +++    +    +    -    -    0    0    0
63    +    -    -    -    -    0    0    0
64    +    +    -    -    +    0    0    0
65    +    -    -    +    +    0    0    0
66    ++    -    -    -    -    0    0    0
67    ++    ++    +    ++    +    0    0    0
68    +    -    -    -    -    0    0    0
69    +    -    ++    -    ++    -    -    -
70    ++    +    +    -    +    -    -    +
71    ++    +    -    -    -    -    -    +
72    -    -    +    -    +    0    0    0
73    -    -    -    -    -    0    0    0
74    +    +    -    -    +    -    -    +
75    ++    -    -    -    -    -    -    +
表7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
76    +++    -    +    -    -    -    -    +
77    -    -    +    -    -    0    0    0
78    -    +    +    +    ++    -    +    +
79    -    ++    +    -    +    0    0    0
80    +    -    -    -    -    0    0    0
81    -    +    -    +    -    0    0    0
82    +++    -    +    -    -    0    0    0
83    ++    -    -    -    -    0    0    0
84    +    +    ++    -    ++    0    0    0
85    +++    +    +    -    -    0    0    0
86    +++    -    -    -    -    0    0    0
87    -    -    +    -    -    0    0    0
88    ++    -    +++    -    -    0    0    0
89    +++    +    +++    -    -    0    0    0
90    +++    -    -    -    -    0    0    0
91    ++    +++    +++    +    +++    0    0    0
92    -    -    ++    -    -    0    0    0
93    ++    -    -    -    -    0    0    0
94    +    -    -    -    -    0    0    0
95    +++    -    -    -    -    -    -    +
96    +    ++    -    -    +    -    -    +
97    +++    -    -    -    +    -    -    -
98    +    +    -    ++    ++    0    0    0
99    -    -    -    +    -    0    0    0
100    -    ++    +    ++    +    0    0    0
101    +    +    -    ++    +    0    0    0
102    +    -    +    +    -    0    0    0
103    ++    -    -    -    -    0    0    0
104    +    -    -    +    -    0    0    0
105    +    -    -    -    -    0    0    0
106    -    -    +    ++    +    0    0    0
107    ++    ++    +    ++    ++    0    0    0
108    ++    -    -    +    -    0    0    0
109    +    +    -    +    -    0    0    0
110    -    -    -    ++    -    0    0    0
111    ++    +    ++    -    -    0    0    0
112    +++    -    -    -    -    0    0    0
113    +++    -    -    -    -    -    -    ++
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
114    ++    -    -    -    +    +    -    -
115    ++    -    -    -    -    0    0    0
116    -    -    +    -    +    0    0    0
117    -    -    +    -    +    0    0    0
118    -    -    +    -    +++    ++    -    +
119    +    +    -    -    ++    +    -    -
120    -    -    +    -    -    0    0    0
121    +    -    +    -    -    0    0    0
122    -    +    -    -    ++    -    -    -
123    +    -    -    -    -    0    0    0
124    ++    +    +    -    +    +    -    +
125    -    +    -    -    +    0    0    0
126    +++    -    +    -    -    +    -    -
127    -    -    -    -    +    0    0    0
128    -    -    -    -    -    0    0    0
129    -    -    ++    -    -    0    0    0
130    +    -    -    -    -    -    -    -
131    +    -    -    +    +    +    -    +
132    -    -    -    -    -    0    0    0
133    +    -    -    -    -    0    0    0
134    ++    -    -    -    -    -    -    -
135    -    -    +    -    -    -    -    -
136    -    -    +    -    -    0    0    0
137    ++    -    +    -    -    -    -    -
138    -    -    -    -    -    0    0    0
139    +    -    -    -    +    0    0    0
140    +    -    -    -    -    0    0    0
141    -    -    -    -    -    0    0    0
142    -    -    +    -    -    0    0    0
143    -    -    +    -    ++    +    -    -
144    -    -    -    -    +    0    0    0
145    -    0    -    -    -    0    0    0
146    +    -    +    -    +    0    0    0
147    ++    +    -    ++    +    0    0    0
148    +    +    -    -    +    0    0    0
149    ++    -    -    ++    -    0    0    0
150    +++    -    -    -    -    0    0    0
151    -    -    -    ++    -    0    0    0
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
152    -    -    -    -    -    0    0    0
153    -    +    -    -    +    0    0    0
154    -    +    -    -    -    0    0    0
155    ++    +    +    -    +    0    0    0
156    -    -    -    -    -    0    0    0
157    +    +    -    ++    +    0    0    0
158    -    -    -    +    -    0    0    0
159    -    +    -    +    +    0    0    0
160    -    -    -    -    -    0    0    0
161    +    -    -    -    +    0    0    0
162    +    -    -    -    -    0    0    0
163    +    -    -    -    -    0    0    0
164    -    -    +    -    -    0    0    0
165    +    -    -    -    -    0    0    0
166    +    -    -    -    -    0    0    0
167    -    -    -    -    -    0    0    0
168    +    -    +    -    -    0    0    0
169    +    -    -    -    -    0    0    0
170    +    -    -    -    -    0    0    0
171    -    -    -    -    -    0    0    0
172    ++    +    ++    -    +    0    0    0
173    +    +    +    -    +    0    0    0
174    ++    +    ++    -    ++    0    0    0
175    +    +    ++    -    +    0    0    0
176    -    -    -    -    -    0    0    0
177    -    -    -    -    -    0    0    0
178    -    -    -    -    -    0    0    0
179    -    -    -    -    ++    0    0    0
180    +    -    -    -    -    0    0    0
181    -    +    -    -    -    0    0    0
182    -    -    -    -    -    0    0    0
183    -    -    -    -    +    0    0    0
184    ++    -    -    ++    -    0    0    0
185    -    -    -    -    -    0    0    0
186    ++    +    -    -    +    0    0    0
187    -    +    -    -    ++    0    0    0
188    +    -    -    -    -    0    0    0
189    +    +    +    -    -    0    0    0
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
190    -    -    -    -    -    0    0    0
191    +++    -    +    -    -    0    0    0
192    +    -    -    -    -    0    0    0
193    +    -    +    -    +    0    0    0
194    -    -    -    -    -    0    0    0
195    -    -    -    -    -    0    0    0
196    -    -    -    ++    -    0    0    0
197    -    -    -    -    -    0    0    0
198    +    +    +    -    +    0    0    0
199    +    +    +    -    -    0    0    0
200    +++    +    -    ++    ++    0    0    0
201    -    -    -    -    +    0    0    0
202    -    -    -    -    -    0    0    0
203    +    -    -    -    -    0    0    0
204    -    -    -    -    -    0    0    0
205    +    -    -    -    -    0    0    0
206    -    -    -    -    -    0    0    0
207    -    -    -    -    -    0    0    0
208    ++    -    +    -    -    0    0    0
209    +    -    +    ++    -    0    0    0
210    -    -    -    ++    -    0    0    0
211    -    -    +    -    -    0    0    0
212    -    -    -    +    -    0    0    0
213    +    +    -    +    -    0    0    0
214    -    -    -    -    ++    0    0    0
215    +    +    -    ++    -    0    0    0
216    -    -    -    +    -    0    0    0
217    +    -    -    ++    -    0    0    0
218    +++    -    -    ++    -    0    0    0
219    ++    -    -    -    -    0    0    0
220    -    -    -    -    -    0    0    0
221    -    +    -    ++    ++    0    0    0
222    ++    -    -    -    +    0    0    0
223    -    -    -    +    -    0    0    0
224    +    -    -    +    -    0    0    0
225    ++    +    +    +    ++    0    0    0
226    -    -    -    -    +    0    0    0
227    -    -    -    -    -    0    0    0
7
化合物    POWD    RICE    LEAF    GRAY    DOWN    LEAF    APPL    LEAF
实例号    MDEW    BLAS    RUST    MOLD    MDEW    SPOT    SCAB    BLOT
228    -    -    -    -    -    0    0    0
229    +    -    -    -    -    0    0    0
230    +    +    +    -    ++    0    0    0
231    -    +    -    -    -    0    0    0
232    -    -    -    -    -    0    0    0
233    -    -    -    -    -    0    0    0
234    +    -    -    -    -    0    0    0
235    +    -    -    -    -    0    0    0
236    -    -    -    -    -    0    0    0
237    +    -    -    -    -    0    0    0
238    +    -    -    -    -    0    0    0
239    +    -    -    -    -    0    0    0
240    ++    +    +    +    -    0    0    0
241    +    +++    +    -    +    0    0    0
242    ++    ++    +    -    +    0    0    0
243    +    -    -    -    +    0    0    0
244    ++    -    +    +    ++    0    0    0
245    +++    ++    -    +++    -    0    0    0
246    +    -    -    -    -    0    0    0
247    -    -    -    -    -    0    0    0
248    -    -    -    -    -    0    0    0
249    -    -    -    -    -    0    0    0
250    -    -    -    -    -    0    0    0
251    -    -    -    -    -    0    0    0
252    -    -    -    -    -    0    0    0
253    +    +    +    -    +    -    +    -
254    +    ++    +    -    ++    0    0    0
255    -    -    -    -    -    0    0    0
256    -    -    -    -    -    0    0    0
257    +    -    -    -    ++    0    0    0
258    -    -    -    -    -    0    0    0
259    +    -    -    -    -    0    0    0
260    -    -    -    -    -    0    0    0
261    -    -    -    -    -    0    0    0
262    -    -    +    0    -    0    0    0
263    -    +    +    -    +    0    0    0
264    -    -    +    -    +    0    0    0
265    -    -    -    -    -    0    0    0
其它植物病理学试验
所选的化合物进一步在温室中对各种病原体进行测试。化合物的配制及叶片喷雾施用同试验1。结果用表7的分级标准分级,示于下列表8-10。
以下各表中采用下列缩写:
PMW=小麦白粉菌
PMB=大麦白粉菌
PMG=葡萄白粉菌
PMC=黄瓜白粉菌
PMA=苹果白粉菌
BG=葡萄葡萄孢
BT=蕃茄葡萄孢
BB=菜豆葡萄孢
DMG=葡萄霜霉
LRW=小麦叶锈菌
LS=小麦叶斑菌
LB=小麦叶疱菌
AS=苹果黑星病
TB=蕃茄疫病
PCH=Pseudocercosporella    herpotuchoides
8
化合物
实施例号    PMW    PMB    PMG    PMC    PMA
1    0    0    0    0    +++
2    +++    ++    +++    +++    +++
4    +++    0    0    0    0
6    ++    0    0    0    0
8    +++    0    0    0    0
9    +++    0    0    0    0
12    -    0    0    0    0
14    +++    0    0    0    ++
16    ++    0    0    0    0
17    +++    0    0    0    0
18    +++    0    0    0    0
20    +++    0    0    0    0
21    +++    0    0    0    0
24    +++    0    0    0    0
28    +++    +++    0    ++    +++
35    ++    0    0    0    0
36    +++    0    0    0    0
52    +++    0    0    0    0
58    +++    0    0    0    ++
60    +++    +    0    +    ++
62    +++    0    0    0    0
75    +++    0    0    0    0
77    -    0    0    0    0
82    +++    0    0    0    0
85    +++    0    0    0    0
86    +++    0    0    0    0
88    ++    0    0    0    0
89    +++    0    0    0    0
90    +++    0    0    0    0
91    ++    0    0    0    0
113    +++    0    0    0    0
126    +++    0    0    0    0
130    +    0    0    0    0
150    ++    0    0    0    0
166    -    0    0    0    0
191    +++    0    0    0    0
8
化合物
实施例号    PMW    PMB    PMG    PMC    PMA
218    -    0    0    0    0
230    ++    0    0    0    0
245    +    0    0    0    0
255    -    0    0    0    0
9
化合物
实施例号    BG    BT    BB    DMG    LRW
2    0    0    0    +    +
28    0    0    0    0    +
31    +++    ++    +    ++    0
32    0    -    0    0    0
33    -    +++    0    0    0
34    0    ++    0    0    0
35    +++    +++    0    0    0
58    0    0    0    0    -
60    0    0    0    0    -
78    0    0    0    ++    0
91    0    0    0    ++    +++
98    0    +++    0    0    0
118    0    0    0    +++    0
119    0    0    0    ++    0
157    0    +    0    0    0
167    0    -    0    0    0
184    0    +    0    0    0
209    ++    0    0    0    0
210    ++    +    0    0    0
245    0    ++    0    0    0
10
化合物
实施例号    LS    LB    AS    TB    PCH
2    0    +    0    0    0
6    +    0    0    0    0
28    0    0    0    0    +
35    +    0    +++    +    0
91    0    0    0    ++    0
113    0    0    0    0    ++
118    0    0    0    +    0
119    0    0    0    ++    0
结合物
已知真菌病病原能够对杀真菌剂产生抗性。如果已经产生了杀真菌剂抗性菌株,则需要施用越来越大量的杀真菌剂才能得到所要求的效果。为延缓对新的杀真菌剂产生抗性,需要与其它杀真菌剂结合来施用新杀真菌剂。使用结合产物还能使产物的活性谱得以调节。
因此,本发明的另一方面是一种杀真菌剂结合物,它含有至少1%重量的式(1)化合物与第二种杀真菌剂结合。
可望从中选择第二种杀真菌剂的杀真菌剂类型包括:
1)N-取代吡咯类,例如Propiconazole、***二甲酮、flusilazol、diniconazole、ethyltrianol、myclobutanil、prochloraz;
2)嘧啶类,如双氯苯嘧醇和nuarimol;
3)吗啉类,如fenpropimorph和环吗啉;
4)哌嗪类,如嗪胺灵;
5)吡啶类,如Pyrifenox。
这五类杀真菌剂的作用都是抑制固醇的生物合成。另一些类型的具有其它作用机理的候选杀真菌剂包括:
6)二硫代氨基甲酸酯类,如代森锰和代森锰锌;
7)邻苯二甲酰亚胺类,如敌菌丹;
8)间苯二腈类,如百菌清;
9)二甲酰亚胺类,如二氯苯基甲乙基二氧咪唑羧酰胺;
10)苯并咪唑类,如苯菌灵和多菌灵;
11)2-氨基嘧啶类,如乙嘧醇;
12)甲酰胺类,如萎锈灵;
13)二硝基苯酚类,如消螨普。
本发明的杀真菌剂结合物含式(1)化合物的重量至少为1%,通常为20-80%,更典型的是50-75%。
已发现本发明的某些结合物对抵抗许多真菌病原体具有增效活性。对抵抗白粉菌和锈菌的增效作用不仅已在温室试验中观察到,而且在大田条件观察到。
更具体地说,已对某些结合物观察到了增效作用,这些结合物中的第二杀真菌剂成分为nuarimol、苯菌灵、百菌清、prochloraz、propiconazole、***二甲酮、或环吗啉。在这样一些结合物中测试了实施例2、14、28、35和60化合物。一般认为,在适当条件下,可以期望某些结合物具有增效作用,这些结合物中含有式(1)化合物与抑制C-14脱甲基类型的固醇抑制性杀真菌剂结合;但是,如前面的列举所示,用其它类型的杀真菌剂也观察到了增效作用。
在提到某个组合物显示出增效作用时,是指在该组合物的试验中
观察到的病害控制百分比超过了由下列公式推算的值:
E=X+Y- (XY)/100
式中X为组分A以浓度p施用而进行试验时所观察到的控制百分比,Y为组分B以浓度q施用而进行试验时所观察到的控制百分比,E为A+B结合而以浓度P+q施用时所预期的控制百分比。这一检验方法是以S.R.Colby的论文为基础的(S.R.Colby,“Calculating    Synergistic    and    Antagonistic    Responses    of    Herbicide    Combinations”,Weeds,15:20-22,1967)。该检验法是建立在这样一种理论的基础上的,即,如果组分A和B彼此独立地各杀伤50%的病原生物,则若A和B共同使用,在A杀伤50%病原生物后,B预期最多能杀伤其余病原生物的50%,从而达到预期的75%的总控制率。
一种给定的杀真菌剂组合物可能在某些条件下显示增效作用而在另一些条件下不显示。对确定是否显示增效作用有意义的因素包括,例如施用率、施用时间、病原生物对组合物的某个组分的遗传抗性。如果结合物的施用率大到仅一个组分的施用量就能完全控制病原生物,就没有什么改进的余地了,并且该结合物的增效能力可能不明显。就时间的选择而言,如果在真菌病原生物旺盛生长之前施用杀真菌剂,则该生物较为敏感,因而表现增效能力的机会较病原生物旺盛生长的情况为小。另一方面,如果病原生物对结合物的一个组分具有遗传抗性,使得仅一个组分的施用量对该特定生物没有什么控制效果,则结合物对抵抗该生物表现增效作用的机会较大,而在对非抗性病原生物
使用相同的施用浓度时这种机会较小。
螨/昆虫筛选
在下列螨/昆虫筛选中,测试实施例1-265化合物的杀螨活性和杀昆虫活性。
每个试验化合物的配制都是将化合物溶于丙酮/乙醇(50∶50)混合液中,每升该混合液中含有23克“Toximul    R”(磺酸盐/非离子性表面活性剂掺合物)和13克“Toximul    S”(磺酸盐/非离子性表面活性剂掺合物)。然后用水稀释这些混合液而得到指定浓度。
将棉叶螨(Tetranychus urticae Koch)和棉蚜(Aphis gossypii Glover)放在南瓜子叶上,使其在叶片两面生长繁殖。使栽在同一处理的花盆中的植物不受侵染。然后用DeVilbiss自动喷雾器以10磅/英寸2的压力对叶片喷洒5毫升试验溶液。使药液覆盖叶片的两面直至径流,然后令其干燥1小时。切下两片未侵染的叶片放在装有南方灰翅夜蛾(Spodoptera eridania Cramer)的培养皿中。
为评价对黄瓜十一星叶甲食根亚种(Diabrotica    undecimpunctata    howardi    Barber)的活性,在一个一盎司的塑料容器中加入2毫升自来水、一粒预浸过的玉米种子及15克干砂壤土。用1毫升含预定浓度试验化合物的试验溶液处理土壤。干燥6至12小时后,每杯分别放入五只2-3龄的叶甲幼虫,然后盖好于23℃下放置。
标准接触期过后,评价死亡百分率和植物毒性。有活性的化合物的测定结果示于表11。其余化合物不显示活性。表11中采用了下
列缩写:
CRW是指黄瓜十一星叶甲
SAW是指南方灰翅夜蛾
SM是指棉叶螨
MA是指棉蚜。
11
SAW
CRW    CRW    SM    &    MA    SAW    SM    MA
实例号    浓度    结果    浓度    结果    结果    结果
PPM    %    PPM    %    %    %
2    12.00    0    200    0    0    10
12    24.00    0    400    0    90    0
12.00    0    200    0    40    0
21    24.00    0    400    0    40    50
48    24.00    0    400    0    70    60
83    24.00    0    400    0    0    80
12.00    0    200    0    0    0
94    24.00    100    400    0    0    0
12.00    0    200    0    0    0
108    24.00    100    400    0    0    0
12.00    0    200    0    0    0
122    12.00    100    200    0    0    0
12.00    100    200    100    0    0
155    24.00    100    400    0    0    0
12.00    0    200    0    0    80
160    24.00    100    400    0    90    90
12.00    100    200    0    0    0
168    12.00    0    200    0    30    0
172    24.00    0    400    0    80    80
181    24.00    0    400    100    0    0
12.00    60    200    0    0    0
197    24.00    0    400    80    0    0
12.00    0    200    0    0    0
208    24.00    0    400    0    0    0
12.00    0    200    0    0    80
224    24.00    80    400    0    0    0
12.00    0    200    0    0    0
254    24.00    100    400    0    0    0
12.00    0    200    0    0    80
264    24.00    0    400    60    0    0
12.00    0    200    0    0    0
组    合    物
本发明的化合物是以组合物的形式施用的,这些组合物是本发明的重要实施方案,它们含有本发明化合物和植物学上可接受的惰性载体。这些组合物或者是分散于水中施用的浓缩制剂,或者是无需进一步处理就可施用的粉剂或颗粒制剂。这些组合物按农业化学领域内常规方法和配方来配制,但这些方法和配方新颖且重要,因为其中有本发明的化合物。不管怎样,下面将给出有关组合物配制方法的一些描述,以确保农业化学家能容易地配制任何所需的组合物。
施用化合物所用的分散体系最常见的是由化合物的浓缩制剂制备的水悬浮液或乳液。这类水溶性、水悬浮性、或可乳化的制剂,或者是通常称为可湿性粉剂的固体,或者是通常称为乳油或水悬浮液的液体。可湿性粉剂可压制成可分散于水中的颗粒,它们是含有活性化合物、惰性载体和表面活性剂的紧密混合物。活性化合物的浓度通常约为10%至90%(重量)。惰性载体通常选自硅镁土、蒙脱土、硅藻土、或纯化的硅酸盐。有效的表面活性剂约占0.5%至10%的可湿性粉剂,这些表面活性剂选自磺化木素、稠合萘磺酸盐、萘磺酸盐、烷基苯磺酸盐、烷基硫酸盐、以及非离子型表面活性剂如烷基苯酚的环氧乙烷加合物。
这些化合物的乳油制剂含有方便浓度例如液体重量的约10%至约50%的溶解在惰性载体中的化合物,惰性载体或者是可与水互溶的溶剂,或者是水不溶性有机溶剂与乳化剂的混合物。有用的有机溶剂包括芳香族化合物尤其是二甲苯,石油的某些馏分尤其是石油的高沸点萘部分和烯烃部分(如重芳香石脑油)。也可以应用其他有机溶剂如萜类溶剂,包括松香衍生物、脂肪族酮类(如环己酮)、及
复合醇类(如2-乙氧基乙醇)。适用于乳油制剂的乳化剂选自常规非离子型表面活性剂,如前面提到的表面活性剂。
水悬浮剂含有分散于水性载体中的本发明水不溶性化合物的悬浮物,其浓度范围约为5%至50%(重量)。悬浮剂的制备方法是,将化合物精细研磨,将其与由水和选自上述同一类型的表面活性剂组成的载体充分混合。还可以加入惰性成分如无机盐和合成树胶或天然树胶,以增加水性载体的密度和粘度。同时研磨和混合化合物常常最为有效,方法是先制备水性混合物,然后在诸如砂磨、球磨、或活塞式均化器等工具中进行均化。
这些化合物还可以作为颗粒状组合物来施用,这特别适用于土壤施用。颗粒状组合物通常含有约0.5%至约10%(重量)的分散于惰性载体中的化合物,惰性载体则全部或大部分由粘土或类似的廉价物质组成。这类组合物的制备方法通常是将化合物溶于合适的溶剂中,将其涂到预制成适当粒度(0.5至3mm的范围内)的颗粒载体上。配制这类组合物时也可以先制出载体和化合物的捏塑体或糊状物,然后粉碎并干燥得所要求的颗粒粒度。
含有化合物的粉剂的制备方法是简单地使粉状化合物与合适的粉状农用载体(如高岭土、研碎的火山岩等)紧密混合。粉剂可适当含有约1%至约10%的化合物。
已制备出本发明化合物的下列制剂,这些制剂是适用于本发明实施的典型组合物。
A.乳    油
7-氯-4-(4-氟苯氧基)喹啉    12.50%
“TOXIMUL    D”    1.75%
(非离子型/阴离子型表面活性剂掺合物)
“TOXIMUL    H”    3.25%
(非离子型/阴离子型表面活性剂掺合物)
“PANASOL    AN3N”    64.50%
(萘类溶剂)
“DOWANOL    PM”  18.00%
(丙二醇单甲基醚)
B.干流动剂
7-氯-4-(4-氟苯氧基)喹啉    18.13%
“STEPANOL    M.E.”(阴离子
表面活性剂)    2.50%
***树胶    0.50%
“SELLOGEN    HR”    3.00%
(阴离子型分散剂和润滑剂)
“HISIL    233”    3.00%
(二氧化硅载体)
“POLYFON    H”    4.00%
(木素磺酸盐分散剂)
高岭土    8.87%
C.可湿性粉剂
7-氯-4-(4-氟苯氧基)喹啉    78.125%
“STEPANOL    ME”    5.000%
“HISIL    233”    5.000%
“POLYFON    H”    5.000%
高岭土    6.875%
D.水悬浮液
7-氯-4-(4-氟苯氧基)喹啉    12.5%
“MAKON    10”    1.0%
(10摩尔环氧乙烷壬基苯酚表面活性剂)
“ZEOSYL    200”(二氧化硅)    1.0%
“POLYFON    H”    0.2%
“AF-100”    0.2%
(硅基防泡剂)
2%合成生物聚合胶溶液    10.0%
自来水    75.1%
E.水悬浮液
5,7-二氯-4-(4-氟苯氧基)喹啉    12.5%
“MAKON    10”    1.0%
“ZEOSYL    200”    1.0%
“AF-100”    0.2%
“POLYFON    H”    0.2%
2%合成生物聚合胶溶液    10.0%
自来水    75.1%
F.水悬浮液
5,7-二氯-4-(4-氟苯氧基)喹啉    12.5%
“TOXIMUL    D”    2.0%
“TOXIMUL    H”    2.0%
“EXXON    200”(萘类溶剂)    83.5%
G.乳    油
8-氯-4-(2-氯苯氧基)喹啉    17.8%
“TOXIMUL    D”    2.5%
“TOXIMUL    H”    2.5%
“EXXON    200”    77.2%
H.乳    油
8-氯-4-(2-氯苯氧基)喹啉    12.5%
“TOXIMUL    D”    2.5%
“TOXIMUL    H”    2.5%
“EXXON    200”    82.5%
I.乳    油
8-氯-4-(2-氯-4-氟苯氧基)喹啉    17.6%
“TOXIMUL    D”    2.5%
“TOXIMUL    H”    2.5%
“EXXON    200”    77.4%
J.乳    油
8-氯-4-(2-氯-4-氟苯氧基)喹啉    12.5%
“TOXIMUL    D”    2.5%
“TOXIMUL    H”    2.5%
“EXXON    200”    82.5%
K.乳    油
5,7-二氯-4-(4-氟苯氧基)喹啉    12.5%
“TOXIMUL    D”    2.0%
“TOXIMUL    H”    2.0%
“EXXON    200”    83.5%
L.可湿性粉剂
8-氯-4-(2-氯-4-氟苯氧基)喹啉    25.8%
“SELLOGEN    HR”    5.0%
“POLYFON    H”    4.0%
“STEPANOL    ME    DRY”    2.0%
“HISIL    233”    3.0%
高岭土    60.2%

Claims (11)

1、一种植物杀真菌制剂,该制剂含有有效杀真菌量的式(1)化合物或式(1)化合物的酸加成盐、或Y为CH的式(1)化合物的N-氧化物与植物学上可接受的载体结合,并视需要与第二种植物杀真菌剂结合。
其中
X为CR5或N,其中R5为H、Cl或CH3
如果X为N,则Y为CR5′;如果X为CR5,则Y为CR5′或N,其中R5′为H、Cl或Br;
Z为O、S、SO、SO2、NR6,其中R6为H、(C1-C4)烷基、或(C1-C4)酰基、或CR7R8,其中R7和R8彼此独立地为H、(C1-C4)酰基、(C1-C4)烷基、(C1-C4)链烯基、(C2-C4)炔基、CN。或OH,或R7和R8结合而形成含4至6个碳原子的碳环。
R1至R4彼此独立地为H、OH、NO2、卤素、I、(C1-C4)烷基、(C3-C4)支链烷基、(C1-C4)烷氧基、卤代(C1-C4)烷基、卤代(C1-C4)烷氧基。或卤代(C1-C4)烷硫基;或者R1和R2或R2和R3结合而形成含4至6个碳原子的碳环;
A为
(a)饱和或不饱和、直链或支链的C1-C8碳氢链,其中可含有一个选自O、S、SO、SO2或Si的杂原子,并可被卤素、卤代(C1-C4)烷氧基、羟基、或(C1-C4)酰基取代;
(b)(C3-C8)环烷基或环烯基;
(c)具有式(2)结构的苯基
其中R9至R13彼此独立地为
H、
CN、
NO2
OH、
卤素、
I、
(C1-C4)烷基、
(C3-C4)支链烷基、
(C2-C4)酰基、
卤代(C1-C4)烷基、
羟基(C1-C4)烷基、
(C1-C4)烷氧基、
卤代(C1-C4)烷氧基、
(C1-C4)烷硫基、
卤代(C1-C4)烷硫基、
苯基、
取代的苯基、
苯氧基、
取代的苯氧基、
苯硫基、
取代的苯硫基、
苯基(C1-C4)烷基、
取代的苯基(C1-C4)烷基、
苯甲酰基、
取代的苯甲酰基、
SiR20R21R22或OSiR20R21R22,其中,R20、R21、R22为H、直链或支链C1-C6烷基、苯基、或取代的苯基,条件是,R20、R21和R22至少有一个不为H,或者R11和R12或R12和R13结合而形成一个碳环,条件是,R9至R13中至少有两个为H,除非R9至R13都为H或F;
(d)具有式(3)的呋喃基
式中R14为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基;
(e)具有式(4)的噻吩基
式中R15为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C2-C4)支链烷基、苯基、或(C1-C4)烷氧基;
(f)具有式(5)或(5a)的基团
Figure 891004726_IMG5
式中R16为H、卤素、卤代甲基、CN、NO2、(C1-C4)烷基、(C2-C4)支链烷基、苯基、取代的苯基、或(C1-C4)烷氧基,F为N或CH,G为O、NR19或CH,条件是,或者F为N,或者G为NR19,其中R19为H、(C1-C4)烷基、(C1-C4)酰基、苯磺酰基、
或取代的苯磺酰基;
(g)选自如下基团的基团:
1-萘基、
取代的1-萘基、
4-吡唑基、
3-甲基-4-吡唑基、
1,3-苯并二噁茂基、
三环[3.3.1.1(3.7)]癸-2-基、
1-(3-氯苯基)-1H-四唑-5-基、
吡啶基、
哒嗪基,
条件是,如果A为(d)、(e)、(f)中所述的基团,则Z为CR7R8;如果A为(a)中所述的基团,则Z为S、SO或SO2
2、一种权利要求1的杀真菌制剂,其特征在于,其中的式(1)化合物为如下限定的化合物或其酸加成盐,或Y为CH的化合物的N-氧化物:
X为CR5或N,
如果X为N,则Y为CH,如果X为CR5,则Y为CH或N,
Z为O或CR7R8
A为Ar、Ar1、或Ar2
R1至R4
a)都为H,或
b)R1至R4中,R1为NO2、卤素、I、(C1-C4)烷基、(C3-C4)支链烷基、(C1-C4)烷氧基、卤代(C1-C4)烷氧基、或卤代(C1-C4)烷硫基,其余为H,
c)R1至R4中,R2为NO2、卤素、I、(C1-C3)烷氧基、(C1-C3)烷基、卤代甲氧基、或卤代甲硫基,其余为H,条件是如果R2为NO2,则Ar不为未取代的苯基,
d)R1至R4中,R3为NO2、卤素、I、(C1-C3)烷基、卤代(C1-C3)烷基、(C1-C3)烷氧基、卤代(C1-C3)烷氧基、或卤代(C1-C3)烷硫基,其余为H,条件是如果R3为NO2,则Ar为Ar1基团,
e)R1至R4中,R4为NO2、卤素、I、CH3、或OH,其余为H,条件是如果R4为Cl,则Ar为Ar2基团,如果R4为Br或NO2,则Ar为Ar1基团,
f)R1至R4中,R1和R3彼此独立地为卤素或I,其余为H,条件是Ar不为3-氰苯基,
g)R1至R4中,R1和R2彼此独立地为卤素或I,其余为H,条件是Ar不为2-硝基-4-三氟甲基苯基,
h)R1至R4中,R1和R4彼此独立地为卤素或I,其余为H,条件是Ar不为2-硝基苯基,
i)R1至R4中,R2和R3彼此独立地为卤素或I,其余为H,条件是如R2为Cl,则Ar不为4-氟苯基,
j)R1至R4中,有一个为(C1-C3)烷基、(C1-C3)烷氧基、卤代(C1-C3)烷基、卤代(C1-C3)烷硫基、NO2或OH,另有一个为卤素、(C1-C3)烷基、(C1-C3)烷氧基、卤代(C1-C3)烷氧基、卤代(C1-C3)烷硫基、或NO2,其余为H,条件是如果R3为Cl,则R2不为CH3或OCH3,或
k)R1和R3都为Cl,R2为F,R4为H;
R5为H、Cl或CH3;
R7和R8彼此独立地为H、(C1-C4)酰基、(C1-C4)烷基、CN或OH,或者R7和R8结合形成含4-6个碳原子的碳环;
Ar为具有式(2)结构的苯基
Figure 891004726_IMG6
式中
R9为H、卤素、I、卤代(C1-C3)烷基、卤代(C1-C3)烷硫基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、取代的苯基、(C1-C4)烷氧基、或OH,
R10和R12彼此独立地为H、F、Cl、卤甲基、或NO2;
R11为H、F、Cl、卤甲基、卤代甲硫基、NO2、(C1-C4)烷基、(C3-C4)支链烷基、(C1-C4)烷氧基、苯氧基、或OH;
R13为H、F、或Cl;或
R11和R12或R12和R13结合形成碳环;
条件是,R9至R13至少有两个为H,除非R9至R13都为H或F;
或Ar为
1-萘基、
3-吡啶基、
具有式(3)结构的呋喃基
Figure 891004726_IMG7
式中R14为H、卤素、卤甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基,
具有式(4)结构的噻吩基
式中R15为H、卤素、卤甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基;
具有式(5)或(5a)的基团
Figure 891004726_IMG9
其中R16为H、卤素、卤甲基、CN、NO2、(C1-C4)烷基、(C3-C4)支链烷基、苯基、或(C1-C4)烷氧基,F为N或CH,G为O、NR19或CH,条件是或者F为N,或者G为NR19,其中R19为H、(C1-C4)烷基、(C1-C4)酰基、苯磺酰基、或取代的苯磺酰基;
Ar1为具有式(6)的取代苯基
Figure 891004726_IMG10
其中R17为卤素、CF3或CN,R18为H或F,
Ar2为Ar1、4-氟苯基、或4-异丙基苯基。
3、根据权利要求1的制剂,其特征在于,在其中的式(1)化合物中,X和Y为CH,Z为O,R1为H或Cl,R2为H,R3为Cl,R4为H。
4、根据权利要求1的制剂,其特征在于其中的式(1)化合物为5,7-二氯-4-(4-氟苯氧基)喹啉,或其1-氧化物。
5、根据权利要求1的杀真菌制剂,其特征在于在其中的式(1)化合物中,X和Y为CH,Z为O,R1至R3为H,R4为Cl。
6、根据权利要求1的杀真菌制剂,其特征在于在其中的式(1)化合物中,A为2-氯苯基或2-氯-4-氟苯基。
7、根据权利要求1的杀真菌制剂,其特征在于其中的式(1)化合物为7-氯-4-〔2-(三氟甲基)苯氧基〕喹啉,或其1-氧化物。
8、根据权利要求1的杀真菌制剂,其特征在于其中的式(1)化合物为5,7-二氯-4-苯氧基喹啉,或其1-氧化物。
9、根据权利要求1的杀真菌制剂,其特征在于其中的式(1)化合物为7-氯-4-(2-硝基苯氧基)喹啉,或其1-氧化物。
10、一种杀真菌方法,该方法包括向植物病原体所在地施用抑制病害并且植物学上可接受量的权利要求1的制剂。
11、一种制备如权利要求1所限定的式(1)化合物的方法,该方法包括:
(a)使式(7)化合物与式(8)化合物缩合生成Z为O的式(1)化合物;
Figure 891004726_IMG11
式中R1至R4如对式(1)所限定,
式中A如对式(1)所限定,或
(b)使如上限定的式(7)化合物与式(9)化合物缩合生成Z为S的式(1)化合物;
式中A如对式(1)所限定,
(c)利用常规方法氧化Z为S的式(1)化合物生成Z为SO的式(1)化合物;或
(d)利用常规方法氧化Z为S的式(1)化合物生成Z为SO2的式(1)化合物;或
(e)使如上限定的式(7)化合物与式(12)所示的取代乙腈的钠盐反应,然后进行酸催化脱氰基反应,生成-Z-A为式(13)所示基团的式(1)化合物;
Figure 891004726_IMG12
式中R9至R13如对式(1)所限定
(f)氧化Y为CH的式(1)化合物生成相应的N-氧化物;
条件是下列化合物除外:
1)化合物中,X和Y都为CH,R1至R4中,R3为Cl,其余为H,A为苯基、4-氯苯基、或4-氟苯基;
2)化合物中X和Y都为CH,R1至R4为H,或者R1、R3、R4为H,R2为F,R5为CH3,Z为O;
3)化合物中A为未取代的苯基,R1至R4都为H,或者R1至R4中R2为NO2,其余为H;
4)7-氯-4-〔3-(三氟甲基)苯氧基〕喹啉;
5)6-氟-2-甲基-4-〔2-硝基-4-(三氟甲基)苯氧基〕喹啉;
6)7-氯-4-(4-氯-3,5-二甲基苯氧基)喹啉;
7)7-氯-4-(4-氯-3-甲基苯氧基)喹啉;
8)5-氯-4-〔2,6-二硝基-4-(三氟甲基)苯氧基〕-2,8-二甲基喹啉;
9)8-氯-2-甲基-4-〔2-硝基-4-(三氟甲基)苯氧基〕喹啉;
10)化合物中Z为NR6
CN89100472A 1988-01-29 1989-01-27 具有杀真菌活性的喹啉化合物的制备方法 Expired - Lifetime CN1031263C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15026688A 1988-01-29 1988-01-29
US150,266 1988-01-29

Publications (2)

Publication Number Publication Date
CN1034925A true CN1034925A (zh) 1989-08-23
CN1031263C CN1031263C (zh) 1996-03-13

Family

ID=22533768

Family Applications (1)

Application Number Title Priority Date Filing Date
CN89100472A Expired - Lifetime CN1031263C (zh) 1988-01-29 1989-01-27 具有杀真菌活性的喹啉化合物的制备方法

Country Status (22)

Country Link
US (2) US5145843A (zh)
EP (1) EP0326330B1 (zh)
JP (1) JP2559485B2 (zh)
KR (1) KR970010174B1 (zh)
CN (1) CN1031263C (zh)
AT (1) ATE221051T1 (zh)
AU (1) AU626279B2 (zh)
BR (1) BR8900356A (zh)
CA (1) CA1340470C (zh)
DE (1) DE68929418T2 (zh)
DK (1) DK36589A (zh)
EG (1) EG18859A (zh)
ES (1) ES2176173T3 (zh)
FI (1) FI94523C (zh)
HU (1) HU208611B (zh)
IL (1) IL89029A (zh)
MX (1) MX14665A (zh)
MY (1) MY104926A (zh)
NL (1) NL350008I2 (zh)
NZ (1) NZ227735A (zh)
TR (1) TR27528A (zh)
ZA (1) ZA89626B (zh)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105660657A (zh) * 2012-05-31 2016-06-15 陕西韦尔奇作物保护有限公司 一种含苯氧喹啉与***类的杀菌组合物
CN108349897A (zh) * 2015-10-29 2018-07-31 拜耳作物科学股份公司 三取代甲硅烷基苯氧基杂环以及类似物
CN109970959A (zh) * 2019-03-26 2019-07-05 华南理工大学 聚噌啉电解质化合物及其制备方法与应用
CN110194761A (zh) * 2019-07-05 2019-09-03 华东理工大学 喹唑啉基羧酸酯类衍生物及其抗菌用途
CN111303135A (zh) * 2020-04-01 2020-06-19 中科利健制药(广州)有限公司 4-(4-吡唑氧基)喹啉类化合物、其制备方法、药物组合物与应用
CN112931513A (zh) * 2021-02-08 2021-06-11 菏泽龙歌植保技术有限公司 一种杀菌剂、制备方法及其应用
CN113549053A (zh) * 2020-04-23 2021-10-26 沈阳中化农药化工研发有限公司 一种吡唑喹(唑)啉醚类化合物及其应用
CN115466212A (zh) * 2022-10-26 2022-12-13 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用

Families Citing this family (170)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114939A (en) * 1988-01-29 1992-05-19 Dowelanco Substituted quinolines and cinnolines as fungicides
IL89027A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
IL89026A (en) * 1988-01-29 1993-02-21 Lilly Co Eli Substituted quinolines and cinnolines, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
IL89028A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives
US5294622A (en) * 1988-01-29 1994-03-15 Dowelanco Substituted quinolines and cinnolines
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
HUT54991A (en) * 1989-08-11 1991-04-29 Ici Plc Process for producing quinoline derivatives and pharmaceutical compositions comprising such compounds
GB9010394D0 (en) * 1990-05-09 1990-06-27 Ici Plc Heterocyclic compounds
US5976848A (en) * 1990-08-03 1999-11-02 Dow Agrosciences Llc Method of identifying potential fungicides using dihydroorotate dehydrogenase inhibition assay
US5202329A (en) * 1991-01-31 1993-04-13 Mitsui Toatsu Chemicals Inc. Pyrimidinyloxy(thio)quinoline derivative, and agri-horticultural fungicide comprising the derivative as active ingredient
CA2060282C (en) * 1991-01-31 1997-11-25 Katsutoshi Ishikawa Pyrimidinyloxy(thio) quinoline derivative, preparation process of the derivative, and agri-horticultural fungicide comprising the derivative as active ingredient
US6004979A (en) * 1991-02-07 1999-12-21 Hoechst Marion Roussel Nitrogenous bicycles
MX9200299A (es) * 1991-02-07 1992-12-01 Roussel Uclaf Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen.
GB9102804D0 (en) * 1991-02-11 1991-03-27 Ici Plc Heterocyclic derivatives
AU1625192A (en) * 1991-05-31 1992-12-03 Zeneca Limited Heterocyclic derivatives
GB9113628D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic derivatives
GB9113626D0 (en) * 1991-06-25 1991-08-14 Ici Plc Heterocyclic compounds
EP0597003A1 (en) * 1991-08-02 1994-05-18 Pfizer Inc. Quinoline derivatives as immunostimulants
US5227387A (en) * 1991-09-03 1993-07-13 Dowelanco Quinoline nematicidal method
US5399564A (en) * 1991-09-03 1995-03-21 Dowelanco N-(4-pyridyl or 4-quinolinyl) arylacetamide and 4-(aralkoxy or aralkylamino) pyridine pesticides
US5245036A (en) * 1992-05-07 1993-09-14 Dowelanco Process for the preparation of 4-phenoxyquinoline compounds
DE4308014A1 (de) * 1993-03-13 1994-09-15 Hoechst Schering Agrevo Gmbh Kondensierte Stickstoffheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
EP0748799B1 (en) * 1994-03-01 2002-09-11 Ishihara Sangyo Kaisha, Ltd. Process for producing 5,7-dichloro-4-hydroxyquinoline
GB9510757D0 (en) * 1994-09-19 1995-07-19 Wellcome Found Therapeuticaly active compounds
US5484761A (en) * 1994-10-11 1996-01-16 Monsanto Company 5-methoxy pyridinyloxypridazines, herbicidal compositions and use thereof
DE4438807A1 (de) * 1994-10-31 1996-05-02 Hoechst Schering Agrevo Gmbh Heterocyclyl-amino- und Heterocyclyl-oxy-cycloalkenyl-Derivate, ihre Verwendung als Schädlingsbekämpfungsmittel und Fungizide
TW321649B (zh) * 1994-11-12 1997-12-01 Zeneca Ltd
GB9424233D0 (en) * 1994-11-30 1995-01-18 Zeneca Ltd Quinazoline derivatives
DE4444911A1 (de) * 1994-12-16 1996-06-27 Basf Ag Fungizide Mischung
US5658902A (en) * 1994-12-22 1997-08-19 Warner-Lambert Company Quinazolines as inhibitors of endothelin converting enzyme
AU5148696A (en) * 1995-04-08 1996-10-30 Basf Aktiengesellschaft Synergistic fungicide compositions made of quinoline derivat ives and cytochrom b/c inhibitors
GB9508537D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
GB9508565D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quiazoline derivative
AU5343096A (en) * 1995-04-27 1996-11-18 Zeneca Limited Quinazoline derivatives
GB9508535D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivative
GB9508538D0 (en) * 1995-04-27 1995-06-14 Zeneca Ltd Quinazoline derivatives
EP0852579A1 (de) * 1995-09-12 1998-07-15 Basf Aktiengesellschaft Fungizide chinoline
GB9624482D0 (en) * 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SK285141B6 (sk) * 1996-02-13 2006-07-07 Astrazeneca Uk Limited Použitie chinazolínového derivátu, chinazolínový derivát, spôsob jeho prípravy a farmaceutická kompozícia, ktorá ho obsahuje
GB9603097D0 (en) * 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline compounds
GB9603095D0 (en) 1996-02-14 1996-04-10 Zeneca Ltd Quinazoline derivatives
KR100489174B1 (ko) 1996-03-05 2005-09-30 제네카-파마 소시에떼아노님 4-아닐리노퀴나졸린유도체
DE69734149T2 (de) 1996-03-15 2006-07-06 Astrazeneca Ab Cinoline derivate und verwendung als heilmittel
GB9607729D0 (en) * 1996-04-13 1996-06-19 Zeneca Ltd Quinazoline derivatives
GB9707800D0 (en) 1996-05-06 1997-06-04 Zeneca Ltd Chemical compounds
WO1997042192A1 (de) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
WO1998005647A1 (en) * 1996-08-01 1998-02-12 Dow Agrosciences Llc Quinolinium derivatives having fungicidal activity
AU4045897A (en) * 1996-08-01 1998-02-25 Dow Agrosciences Llc 1,2-dihydroquinoline derivatives having fungicidal activity
JP2002505660A (ja) 1996-09-10 2002-02-19 ファルマシア・アンド・アップジョン・カンパニー 抗ウィルス剤としての8―ヒドロキシ―7―置換キノリン
AU733551B2 (en) 1996-09-25 2001-05-17 Astrazeneca Ab Qinoline derivatives inhibiting the effect of growth factors such as VEGF
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
ATE237591T1 (de) * 1997-01-31 2003-05-15 Dow Agrosciences Llc Verbessertes verfahren zur herstellung von halo-4-phenoxychinolinen
GB9709907D0 (en) * 1997-05-15 1997-07-09 Ciba Geigy Ag Novel combinations
AU765004B2 (en) * 1997-05-15 2003-09-04 Syngenta Participations Ag Fungicidal combinations comprising a 4-phenoxyquinoline
TW521072B (en) 1997-06-02 2003-02-21 Meiji Seika Kaisha 4-quinolinol derivatives and fungicides containing the same as an active ingredient used for agriculture and horticulture
US6117884A (en) * 1997-07-31 2000-09-12 Daeuble; John 4-substituted quinoline derivatives having fungicidal activity
AU8816298A (en) 1997-08-22 1999-03-16 Zeneca Limited Oxindolylquinazoline derivatives as angiogenesis inhibitors
TW464471B (en) * 1997-12-18 2001-11-21 Basf Ag Fungicidal mixtures based on amide compounds and pyridine derivatives
US6489348B1 (en) * 1997-12-18 2002-12-03 Basf Aktiengesellschaft Fungicidal mixtures based on amide compounds and pyridine derivatives
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
CN1161352C (zh) 1998-10-08 2004-08-11 阿斯特拉曾尼卡有限公司 喹唑啉衍生物
WO2000035284A1 (en) * 1998-12-17 2000-06-22 Syngenta Participations Ag . Pesticidal aqueous suspension concentrates
UA72490C2 (uk) * 1998-12-22 2005-03-15 Басф Акцієнгезелльшафт Фунгіцидна суміш та спосіб боротьби з фітопатогенними грибами
HU228964B1 (en) 1999-02-10 2013-07-29 Astrazeneca Ab Quinazoline derivatives as angiogenesis inhibitors, process for their preparation and medicaments containing them
GB9904419D0 (en) * 1999-02-25 1999-04-21 Univ Liverpool 4-aminoquinolines
GB9910579D0 (en) * 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
GB9910580D0 (en) 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
DE19933938A1 (de) * 1999-07-20 2001-01-25 Bayer Ag Fungizide Wirkstoffkombinationen
ATE398120T1 (de) 1999-11-05 2008-07-15 Astrazeneca Ab Neue quinazolin-derivate
US6552039B2 (en) 1999-11-12 2003-04-22 Syngenta Crop Protection, Inc. Fungicidal combinations comprising a 4-phenoxyquinoline
ES2197124T3 (es) 1999-12-13 2004-01-01 Bayer Cropscience Ag Combinaciones de productos activos fungicidas.
EP1274692B1 (en) 2000-04-07 2006-08-02 AstraZeneca AB Quinazoline compounds
DE10019758A1 (de) * 2000-04-20 2001-10-25 Bayer Ag Fungizide Wirkstoffkombinationen
DE10103832A1 (de) * 2000-05-11 2001-11-15 Bayer Ag Fungizide Wirkstoffkombinationen
UA73993C2 (uk) 2000-06-06 2005-10-17 Астразенека Аб Хіназолінові похідні для лікування пухлин та фармацевтична композиція
JP2004505966A (ja) 2000-08-09 2004-02-26 アストラゼネカ アクチボラグ シンノリン化合物
IL153947A0 (en) 2000-08-09 2003-07-31 Astrazeneca Ab Quinoline derivatives having vegf inhibiting activity
RU2267489C2 (ru) 2000-08-21 2006-01-10 Астразенека Аб Производные хиназолина, способ их получения и фармацевтическая композиция
HUP0302221A3 (en) * 2000-09-20 2004-01-28 Merck Patent Gmbh 4-amino-quinazolines
EP1318985A2 (en) * 2000-09-20 2003-06-18 MERCK PATENT GmbH 4-amino-quinazolines
EP1337513A1 (en) 2000-11-02 2003-08-27 AstraZeneca AB 4-substituted quinolines as antitumor agents
EP1337524A1 (en) 2000-11-02 2003-08-27 AstraZeneca AB Substituted quinolines as antitumor agents
DK1370552T3 (da) * 2001-03-23 2007-05-07 Bayer Pharmaceuticals Corp Rho-kinase-inhibitorer
CA2441492C (en) * 2001-03-23 2011-08-09 Bayer Corporation Rho-kinase inhibitors
DE60229046D1 (de) 2001-04-19 2008-11-06 Astrazeneca Ab Chinazolin derivate
DE10141618A1 (de) * 2001-08-24 2003-03-06 Bayer Cropscience Ag Fungizide Wirkstoffkombinationen
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
CA2471577C (en) 2001-12-24 2011-08-02 Astrazeneca Ab Chemical compounds
ES2305435T3 (es) * 2002-01-10 2008-11-01 Bayer Healthcare Ag Inhibidores de la rho-quinasa.
CA2473910C (en) * 2002-01-23 2011-03-15 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
WO2003062225A1 (en) * 2002-01-23 2003-07-31 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
CA2473572C (en) 2002-02-01 2011-05-10 Astrazeneca Ab Quinazoline compounds
EP1642499B1 (de) 2002-03-01 2008-06-11 Basf Se Fungizide Mischungen auf der Basis von Prothioconazole und Picoxystrobin
EP2308303B1 (de) 2002-03-21 2016-03-16 Basf Se Fungizide Mischungen
TW200813014A (en) 2002-03-28 2008-03-16 Astrazeneca Ab Quinazoline derivatives
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
CA2480614A1 (en) * 2002-04-05 2003-10-16 Basf Aktiengesellschaft Fungicidal mixtures based on benzamidoxime derivatives and a strobilurin derivative
GB0215823D0 (en) 2002-07-09 2002-08-14 Astrazeneca Ab Quinazoline derivatives
JP2005536486A (ja) 2002-07-09 2005-12-02 アストラゼネカ アクチボラグ 癌の処置に使用するためのキナゾリン誘導体
AU2003257666A1 (en) 2002-08-23 2004-03-11 Kirin Beer Kabushiki Kaisha COMPOUND HAVING TGFss INHIBITORY ACTIVITY AND MEDICINAL COMPOSITION CONTAINING THE SAME
CN1327768C (zh) * 2002-10-30 2007-07-25 明治制果株式会社 用于防治水稻病害的杀真菌组合物
GB0225579D0 (en) 2002-11-02 2002-12-11 Astrazeneca Ab Chemical compounds
ATE438644T1 (de) 2002-12-24 2009-08-15 Astrazeneca Ab Chinazolinderivate
GB0309850D0 (en) 2003-04-30 2003-06-04 Astrazeneca Ab Quinazoline derivatives
EP1660092A2 (en) * 2003-07-03 2006-05-31 Myriad Genetics, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
US8309562B2 (en) * 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
US8318752B2 (en) 2003-09-19 2012-11-27 Astrazeneca Ab 4-(3-chloro-2-fluoroanilino)-7-methoxy-6-{[1-(N-methylcarbamoyl-methyl)piperidin-4-yl]oxy}quinazoline, its pharmaceutically acceptable salts, and pharmaceutical compositions comprising the same
JP2007507453A (ja) * 2003-10-01 2007-03-29 ビーエーエスエフ アクチェンゲゼルシャフト 殺菌混合物
GB0326459D0 (en) 2003-11-13 2003-12-17 Astrazeneca Ab Quinazoline derivatives
KR100807920B1 (ko) 2003-12-23 2008-02-27 화이자 인코포레이티드 신규한 퀴놀린 유도체
GB0330002D0 (en) 2003-12-24 2004-01-28 Astrazeneca Ab Quinazoline derivatives
US20080206220A1 (en) * 2004-02-19 2008-08-28 F2G Ltd 2031 Oxidoreductase
TW200538120A (en) * 2004-02-20 2005-12-01 Kirin Brewery Compound having TGF-beta inhibitory activity and pharmaceutical composition containing same
EP2255627A3 (de) 2004-04-30 2012-09-26 Basf Se Fungizide Mischungen
ATE501148T1 (de) 2004-12-14 2011-03-15 Astrazeneca Ab Pyrazolopyrimidinverbindungen als antitumormittel
US8258145B2 (en) * 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
EP1833482A4 (en) 2005-01-03 2011-02-16 Myriad Genetics Inc COMPOUNDS AND ITS THERAPEUTIC USE
WO2006090163A1 (en) 2005-02-26 2006-08-31 Astrazeneca Ab Quinazoline derivatives as tyrosine kinase inhibitors
DE102005015677A1 (de) 2005-04-06 2006-10-12 Bayer Cropscience Ag Synergistische fungizide Wirkstoffkombinationen
US8754009B2 (en) 2005-06-09 2014-06-17 Bayer Cropscience Ag Active compound combinations
DE102005026482A1 (de) 2005-06-09 2006-12-14 Bayer Cropscience Ag Wirkstoffkombinationen
AU2006290766A1 (en) * 2005-09-16 2007-03-22 Basf Aktiengesellschaft Triazole-based fungicidal mixtures
JP2009508918A (ja) 2005-09-20 2009-03-05 アストラゼネカ アクチボラグ 癌治療のためのerbB受容体チロシンキナーゼ阻害剤としての4−(1H−インダゾール−5−イル]アミノ)キナゾリン化合物
EP1991530A1 (en) * 2006-02-21 2008-11-19 Amgen Inc. Cinnoline derivatives as phosphodiesterase 10 inhibitors
JP2009527562A (ja) * 2006-02-21 2009-07-30 アムゲン インコーポレイティッド ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体
US20090099175A1 (en) * 2006-03-01 2009-04-16 Arrington Mark P Phosphodiesterase 10 inhibitors
JP2009529060A (ja) * 2006-03-08 2009-08-13 アムゲン インコーポレイティッド ホスホジエステラーゼ10阻害剤としてのキノリン及びイソキノリン誘導体
AU2007299001B2 (en) 2006-09-18 2013-11-07 Basf Se Pesticidal mixtures comprising an anthranilamide insecticide and a fungicide
EP2164323A1 (en) 2006-12-15 2010-03-24 Rohm and Haas Company Mixtures comprising 1-methylcyclopropene
BR122019020351B1 (pt) 2007-02-06 2020-08-18 Basf Se Misturas, composição pesticida, método para controlar fungos nocivos fitopatogênicos, método para proteger plantas do ataque ou infestação pelos insetos, acarídeos ou nematôdeos e método para proteger semente
WO2008129060A2 (en) 2007-04-23 2008-10-30 Basf Se Plant produtivity enhancement by combining chemical agents with transgenic modifications
CA2700131C (en) 2007-09-26 2016-02-23 Horst Dieter Brix Ternary fungicidal compositions comprising boscalid and chlorothalonil
DE102007045920B4 (de) 2007-09-26 2018-07-05 Bayer Intellectual Property Gmbh Synergistische Wirkstoffkombinationen
BRPI0912170A2 (pt) 2008-05-13 2015-10-13 Astrazeneca Ab composto, forma a, processo para a preparação da mesma, composição farmacêutica, uso de um composto, e, método para tratar um câncer em um animal de sangue quente
EP2453750A2 (de) 2009-07-16 2012-05-23 Bayer CropScience AG Synergistische wirkstoffkombinationen mit phenyltriazolen
WO2011026796A1 (en) 2009-09-01 2011-03-10 Basf Se Synergistic fungicidal mixtures comprising lactylates and method for combating phytopathogenic fungi
CN103269589A (zh) 2010-12-20 2013-08-28 巴斯夫欧洲公司 包含吡唑化合物的农药活性混合物
EP2481284A3 (en) 2011-01-27 2012-10-17 Basf Se Pesticidal mixtures
WO2012116137A2 (en) * 2011-02-24 2012-08-30 Emory University Jab1 blocking compositions for ossification and methods related thereto
WO2012127009A1 (en) 2011-03-23 2012-09-27 Basf Se Compositions containing polymeric, ionic compounds comprising imidazolium groups
CN102718701B (zh) 2011-03-30 2014-05-07 中国中化股份有限公司 芳氧基二卤丙烯醚类化合物与应用
US20140151548A1 (en) * 2011-07-08 2014-06-05 Mitsuru Shindo Matrix for maldi mass spectrometry and maldimass spectrometry method
KR101661825B1 (ko) * 2011-08-03 2016-09-30 내셔널 타이완 유니버시티 Src 상동성-2 함유 단백질 티로신 포스파타제-1의 작용물질 및 그를 사용한 치료방법
CN102952087B (zh) * 2011-08-19 2015-03-18 中国中化股份有限公司 一种含有喹唑啉环的醚类化合物及其用途
CN102952081B (zh) * 2011-08-19 2014-10-22 中国中化股份有限公司 一种含有噌啉环的醚类化合物及其用途
WO2013030338A2 (en) 2011-09-02 2013-03-07 Basf Se Agricultural mixtures comprising arylquinazolinone compounds
BR122019015125B1 (pt) 2012-06-20 2020-04-07 Basf Se mistura pesticida, composição, composição agrícola, métodos para o combate ou controle das pragas de invertebrados, para a proteção dos vegetais em crescimento ou dos materias de propagação vegetal, para a proteção de material de propagação vegetal, uso de uma mistura pesticida e métodos para o combate dos fungos fitopatogênicos nocivos e para proteger vegetais de fungos fitopatogênicos nocivos
WO2014056780A1 (en) 2012-10-12 2014-04-17 Basf Se A method for combating phytopathogenic harmful microbes on cultivated plants or plant propagation material
EA030875B1 (ru) 2012-12-20 2018-10-31 Басф Агро Б.В. Композиции, содержащие триазольное соединение
EP2783569A1 (en) 2013-03-28 2014-10-01 Basf Se Compositions comprising a triazole compound
US9844218B2 (en) 2013-06-13 2017-12-19 Monsanto Technology Llc Acetyl-CoA carboxylase modulators
WO2014201327A1 (en) * 2013-06-13 2014-12-18 Monsanto Technology Llc Acetyl-coa carboxylase modulators
EP2835052A1 (en) 2013-08-07 2015-02-11 Basf Se Fungicidal mixtures comprising pyrimidine fungicides
WO2015036059A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
TN2016000077A1 (en) 2013-09-16 2017-07-05 Astrazeneca Ab Therapeutic polymeric nanoparticles and methods of making and using same
WO2015036058A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
CN103651374A (zh) * 2013-12-10 2014-03-26 济南凯因生物科技有限公司 防治水稻白粉病的组合物
EP2979549A1 (en) 2014-07-31 2016-02-03 Basf Se Method for improving the health of a plant
ES2774793T3 (es) 2014-10-24 2020-07-22 Basf Se Partículas pesticidas orgánicas
US10674732B2 (en) * 2015-04-29 2020-06-09 The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research Organization Anti-phytopathogenic compositions
EP2910126A1 (en) 2015-05-05 2015-08-26 Bayer CropScience AG Active compound combinations having insecticidal properties
MX2018004109A (es) 2015-10-05 2018-09-27 Univ Columbia Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías.
WO2017178408A1 (en) * 2016-04-15 2017-10-19 Syngenta Participations Ag Microbiocidal silicon containing aryl derivatives
WO2017198196A1 (zh) * 2016-05-18 2017-11-23 王子厚 具有抗肿瘤活性的喹啉衍生物
EP3601228B1 (en) * 2017-03-20 2022-01-19 Syngenta Participations AG Microbiocidal quinoline (thio)carboxamide derivatives
CN109548790B (zh) * 2017-09-27 2021-03-26 沈阳中化农药化工研发有限公司 一种六元环类化合物作为制备杀菌剂的应用
KR102334943B1 (ko) * 2018-12-28 2021-12-06 한국화학연구원 신규 이소퀴놀린 유도체, 이의 제조방법, 및 이를 유효성분으로 함유하는 오토파지 관련 질환의 예방 또는 치료용 약학적 조성물
WO2021155195A1 (en) * 2020-01-29 2021-08-05 Georgetown University Compositions and methods for treating neurodegenerative, neurodevelopmental, myodegenerative, and lysosomal storage disorders
GB202014303D0 (en) * 2020-09-11 2020-10-28 Syngenta Crop Protection Ag Improvements in or relating to organic compounds
US11878013B2 (en) 2021-07-02 2024-01-23 Korea Research Institute Of Chemical Technology Isoquinoline derivative, preparing method thereof, and pharmaceutical composition for preventing or treating autophagy related diseases containing the same as an active ingredient

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD39934A (zh) *
US2530125A (en) * 1946-06-29 1950-11-14 Sterling Drug Inc 4-quinolyl amino compounds and method for their preparation
US2653940A (en) * 1951-01-27 1953-09-29 William S Johnson Process for preparing 4-quinolyl secondary amines
US2883382A (en) * 1957-08-29 1959-04-21 Parke Davis & Co Benzo-quinolylamino-2-[di(beta-chloroethyl)aminomethyl]-phenols
US3075981A (en) * 1958-04-03 1963-01-29 Sterling Drug Inc 1-[aromatic-(lower-alkyl)]-4-(aromaticimino)-1, 4-dihydroquinolines and their preparation
US3075984A (en) * 1958-05-09 1963-01-29 Sterling Drug Inc 1-[(lower-aromatic)-(lower-alkyl)]-4-[(lower-aromatic)-(lower-alkyl) imino]-1, 4-dihydroquinolines and their preparation
US3248292A (en) * 1963-02-06 1966-04-26 Mead Johnson & Co Pharmaceutically active dimethoxyquinazolines
US3266990A (en) * 1963-09-24 1966-08-16 Warner Lambert Pharmaceutical Derivatives of quinazoline
CH492395A (de) * 1966-04-26 1970-06-30 Sandoz Ag Mittel zur Bekämpfung von Pflanzenschädlingen und Verwendung des Mittels
US3470182A (en) * 1967-02-09 1969-09-30 Sandoz Ag 4-amino-substituted quinazolines
DK123301B (da) * 1968-05-09 1972-06-05 Shionogi & Co Analogifremgangsmåde til fremstilling af substituerede 2-methyl-2,3-dihydrothieno[3,2-c]-quinoliner eller syreadditionssalte heraf.
US3800039A (en) * 1970-10-21 1974-03-26 Mead Johnson & Co Antithrombogenic process employing substituted 6,7-dialkoxyquinazolines
US3971783A (en) * 1973-03-07 1976-07-27 Pfizer Inc. 4-Aminoquinazoline derivatives as cardiac stimulants
US3998951A (en) * 1974-03-13 1976-12-21 Fmc Corporation Substituted 2-arylquinazolines as fungicides
GB1496371A (en) * 1975-08-18 1977-12-30 Serdex 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof
GB1582407A (en) * 1977-06-07 1981-01-07 Worcester Controls Uk Ltd Annular seals
JPS53103484A (en) * 1977-02-21 1978-09-08 Takeda Chem Ind Ltd Quinazoline derivatives, process for their preparation and nsecticedes and fungicides
JPS542327A (en) * 1977-06-07 1979-01-09 Sankyo Co Ltd Agricultural and horticultural pesticide
JPS6054924B2 (ja) * 1977-06-07 1985-12-03 三共株式会社 農園芸用殺菌剤
JPS542325A (en) * 1977-06-07 1979-01-09 Sankyo Co Ltd Agricultural and horticultural pesticide
SE448091B (sv) * 1977-12-15 1987-01-19 Roussel Uclaf Nya 2-/(4-kinolinyl)-amino/-5-fluorbensoesyraderivat, forfarande for framstellning derav samt farmaceutiska kompositioner innehallande dessa derivat
JPS5576804A (en) * 1978-12-06 1980-06-10 Sankyo Co Ltd Agricultural and horticultural microbicide
JPS5576803A (en) * 1978-12-06 1980-06-10 Sankyo Co Ltd Agent for controlling noxious life
GB2043061B (en) * 1979-03-05 1983-05-11 Ici Ltd Thienopyrimidine and quinazoline derivatives
US4236912A (en) * 1979-03-05 1980-12-02 The Dow Chemical Company Quinolinyloxyphenoxy and quinolyinylthiophenoxy alkanoic acids and derivatives thereof and methods of herbicidal use
DE2918591A1 (de) * 1979-05-09 1980-11-20 Hoechst Ag Neue 4-substituierte 5,6,7,8-tetrahydrochinoline, ihre herstellung und verwendung
AU541697B2 (en) * 1979-11-19 1985-01-17 Ici Australia Limited Quinoline derivatives
DE3028387A1 (de) * 1980-07-26 1982-02-25 Hoechst Ag, 6000 Frankfurt Derivate des 1,2,4-triazols und imidazols, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel
US4551474A (en) * 1981-02-19 1985-11-05 Hoechst-Roussel Pharmaceuticals Incorporated Methods of alleviating convulsions and pain employing 4-aryloxy-1,2,3,4 tetrahydroisoquinolines
GB2135887A (en) * 1983-03-08 1984-09-12 Sandoz Ltd 4-Alkylamino-quinazolines used as insecticides
FR2549830B1 (fr) * 1983-07-25 1987-04-30 Corbiere Jerome Nouveau procede d'obtention de quinoleines substituees
JPS6165869A (ja) * 1984-09-07 1986-04-04 Kyowa Hakko Kogyo Co Ltd キノリン−n−オキシド誘導体
NL8700083A (nl) * 1986-01-29 1987-08-17 Sandoz Ag Tegen schimmels werkende aminen, werkwijzen voor de bereiding daarvan en hun toepassing.
JPS646261A (en) * 1987-03-31 1989-01-10 Nisshin Flour Milling Co 4-thioquinazoline derivative, its production and antiulcer agent containing said derivative as active component
IL88507A (en) * 1987-12-03 1993-02-21 Smithkline Beckman Intercredit 2,4-diaminoquinazolines, process for their preparation and pharmaceutical compositions comprising them
IL89027A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Quinazoline derivatives, process for their preparation and fungicidal, insecticidal and miticidal compositions containing them
IL89029A (en) * 1988-01-29 1993-01-31 Lilly Co Eli Fungicidal quinoline and cinnoline derivatives, compositions containing them, and fungicidal methods of using them
IL89028A0 (en) * 1988-01-29 1989-08-15 Lilly Co Eli Quinoline,quinazoline and cinnoline derivatives

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105660657A (zh) * 2012-05-31 2016-06-15 陕西韦尔奇作物保护有限公司 一种含苯氧喹啉与***类的杀菌组合物
CN108349897A (zh) * 2015-10-29 2018-07-31 拜耳作物科学股份公司 三取代甲硅烷基苯氧基杂环以及类似物
CN108349897B (zh) * 2015-10-29 2022-03-04 拜耳作物科学股份公司 三取代甲硅烷基苯氧基杂环以及类似物
CN109970959B (zh) * 2019-03-26 2020-08-18 华南理工大学 聚噌啉电解质化合物及其制备方法与应用
CN109970959A (zh) * 2019-03-26 2019-07-05 华南理工大学 聚噌啉电解质化合物及其制备方法与应用
CN110194761A (zh) * 2019-07-05 2019-09-03 华东理工大学 喹唑啉基羧酸酯类衍生物及其抗菌用途
CN110194761B (zh) * 2019-07-05 2021-08-20 华东理工大学 喹唑啉基羧酸酯类衍生物及其抗菌用途
CN111303135A (zh) * 2020-04-01 2020-06-19 中科利健制药(广州)有限公司 4-(4-吡唑氧基)喹啉类化合物、其制备方法、药物组合物与应用
CN113549053A (zh) * 2020-04-23 2021-10-26 沈阳中化农药化工研发有限公司 一种吡唑喹(唑)啉醚类化合物及其应用
CN113549053B (zh) * 2020-04-23 2022-09-13 沈阳中化农药化工研发有限公司 一种吡唑喹(唑)啉醚类化合物及其应用
CN112931513A (zh) * 2021-02-08 2021-06-11 菏泽龙歌植保技术有限公司 一种杀菌剂、制备方法及其应用
CN115466212A (zh) * 2022-10-26 2022-12-13 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用
CN115466212B (zh) * 2022-10-26 2023-09-22 河南农业大学 一种2-三氟甲基喹啉类化合物及其合成方法和应用

Also Published As

Publication number Publication date
EP0326330B1 (en) 2002-07-24
US5145843A (en) 1992-09-08
EP0326330A3 (en) 1990-08-22
DK36589D0 (da) 1989-01-27
MY104926A (en) 1994-07-30
HUT49790A (en) 1989-11-28
NL350008I2 (nl) 2003-07-01
AU2872889A (en) 1989-08-03
ATE221051T1 (de) 2002-08-15
JP2559485B2 (ja) 1996-12-04
TR27528A (tr) 1995-06-07
AU626279B2 (en) 1992-07-30
MX14665A (es) 1994-01-31
FI94523C (fi) 1995-09-25
JPH01246263A (ja) 1989-10-02
CN1031263C (zh) 1996-03-13
EG18859A (en) 1994-09-29
FI94523B (fi) 1995-06-15
US5240940A (en) 1993-08-31
ZA89626B (en) 1989-12-27
DK36589A (da) 1989-09-15
FI890423A0 (fi) 1989-01-27
HU208611B (en) 1993-12-28
KR890011849A (ko) 1989-08-22
KR970010174B1 (ko) 1997-06-21
DE68929418T2 (de) 2002-11-07
NZ227735A (en) 1991-12-23
CA1340470C (en) 1999-03-30
FI890423A (fi) 1989-07-30
IL89029A (en) 1993-01-31
BR8900356A (pt) 1989-09-19
DE68929418D1 (de) 2002-08-29
EP0326330A2 (en) 1989-08-02
ES2176173T3 (es) 2002-12-01
IL89029A0 (en) 1989-08-15

Similar Documents

Publication Publication Date Title
CN1031263C (zh) 具有杀真菌活性的喹啉化合物的制备方法
CN1052379C (zh) 含喹唑啉衍生物的杀虫、杀螨组合物和杀菌组合物以及它们的制备方法和用途
CN1034924A (zh) 喹啉、喹唑啉和噌啉类衍生物
CN1034204C (zh) 新的杀真菌、杀虫/或杀螨组合物及其制备和应用
CN1159278C (zh) 杀真菌方法、化合物和含二苯甲酮的组合物
CN1213658C (zh) 吡啶甲酰胺衍生物、含有其作为有效成分的有害生物防除剂
CN1158267C (zh) 氰硫基-***基衍生物及其作为杀微生物剂的用途
CN1229354C (zh) 酰基硫基-***其衍生物及其作为杀微生物剂的用途
CN1037102C (zh) 含硅的杀真菌化合物的制备方法
CN1017993B (zh) 苯胺基嘧啶衍生物的制备方法
CN1235600A (zh) 杂芳酰基衍生物
CN1215054C (zh) 杀微生物的n-磺酰基甘氨酸炔氧基苯乙基酰胺衍生物
CN1649833A (zh) 脒基苯基化合物及其作为杀真菌剂的应用
CN1038643A (zh) 带杂环的2-烷氧苯氧基硫酰脲类和它们作为除草剂或植物生长调节剂的应用
CN1065268A (zh) 2-吡啶衍生物及其制备方法和农业园艺用杀菌剂
CN1028714C (zh) 含嘧啶衍生物作为活性成分的除草剂组合物
CN86103621A (zh) 制备农业上有用的磺酰胺的方法
CN88102069A (zh) 取代的吲唑类杀虫剂
CN1478082A (zh) 嘧啶类化合物及其用途
CN1543452A (zh) 1,4-二取代苯杀虫剂
CN1014240B (zh) 哒嗪酮衍生物的制备方法
CN1033797A (zh) N-苯基烷基苯甲酰胺类杀真菌剂
CN1022563C (zh) 用于控制(或)预防害虫的哒嗪酮衍生物的制备方法
CN1042144A (zh) 杀虫化合物
CN1052856A (zh) 哌啶衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C53 Correction of patent of invention or patent application
COR Change of bibliographic data

Free format text: CORRECT: PATENTEE; FROM: ELI LILLY COMPANY TO: DOW AGRO SCIENCE

CP01 Change in the name or title of a patent holder

Patentee after: Dow Agrosciences LLC

Patentee before: Eli Lilly and Co.

C15 Extension of patent right duration from 15 to 20 years for appl. with date before 31.12.1992 and still valid on 11.12.2001 (patent law change 1993)
OR01 Other related matters
C17 Cessation of patent right
CX01 Expiry of patent term